Infections, IBD-co-morbidities

IBD_INFECTIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints IBD_BACT_INTEST_INFECTIONS IBD_CMV IBD_TUBERCULOSIS	12327
6. Filter based on genotype QC (FinnGen only)	11790

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_INFECTIONS
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	IBD_BACT_INTEST_INFECTIONS\|IBD_CMV\|IBD_TUBERCULOSIS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Infections, IBD-co-morbidities based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11790	5886	5904
Unadjusted period prevalence (%)	2.40	2.09	2.70
Median age at first event (years)	58.56	54.92	62.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
9207: Matched controls
65741

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.8

323.3

455

347

XCK10

NOMESCO Finland

Photography of fundus of eye

5.5

322.8

740

1020

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

15.5

322.7

350

167

ZXE20

NOMESCO Finland

More than three and less than five hours

3.6

322.0

1306

2874

TPH07

NOMESCO Finland

Cathetrisation of artery

4.0

319.5

1120

2219

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

6.5

318.9

620

719

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.0

317.9

1093

2134

G44.2

ICD-10 Finland

Tension-type headache

4.5

317.7

921

1570

M79.0

ICD-10 Finland

Rheumatism, unspecified

61.7

317.6

236

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

5.7

316.9

711

959

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

32.4

315.8

265

L03

ICPC

Low back symptom/complaint

2.9

315.7

1938

5511

WX722

NOMESCO Finland

PEEP

14.4

313.7

353

182

UKC02

NOMESCO Finland

Cystoscopy

3.4

313.2

1415

3343

N05BA04

ATC

oxazepam; oral

2.8

312.7

2149

6496

C03DA01

ATC

spironolactone; oral

4.1

309.8

1026

1945

N02BF02

ATC

pregabalin; oral

9.1

309.7

459

378

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

6.4

308.9

607

712

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.8

307.7

1747

3781

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

31.4

307.7

628

153

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

53.1

307.7

803

118

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

307.7

2564

6922

A02BC03

ATC

lansoprazole; oral

3.4

307.7

2527

6643

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.2

307.7

1696

4306

205

Kela drug reimbursment

Chronic hypertension

3.6

307.7

2107

4998

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1159.5

307.7

455

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

201.1

307.7

326

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

12.5

307.7

831

516

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

7.3

307.7

3042

4185

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

42.1

307.7

286

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

10.0

307.7

537

404

N02BE01

ATC

paracetamol; systemic, rectal

3.9

307.7

7724

37445

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

8.1

307.7

584

545

R5140

NOMESCO Finland

Monitoring the use of the aid

12.7

307.7

722

439

N02AJ06

ATC

codeine and paracetamol; systemic

3.5

307.7

3372

9413

R11

ICD-10 Finland

Nausea and vomiting

5.0

307.7

893

1372

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

20.1

307.7

335

123

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.1

307.7

1145

1786

L04AA06

ATC

mycophenolic acid; systemic

34.9

307.7

552

120

S06.0

ICD-10 Finland

Concussion

14.4

307.7

829

449

C10AA01

ATC

simvastatin; oral

3.1

307.7

3066

9200

L28

ICPC

Limited function/disability (L)

7.0

307.7

1429

1676

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

4.2

307.7

1749

3475

M17.1

ICD-10 Finland

Other primary gonarthrosis

13.9

307.7

1269

747

A10AE04

ATC

insulin glargine; parenteral

122.7

307.7

801

J01MA14

ATC

moxifloxacin; systemic

4.7

307.7

1028

1702

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

8.7

307.7

618

538

R60.0

ICD-10 Finland

Localized oedema

4.5

307.7

956

1656

R03AC02

ATC

salbutamol; inhalant

2.5

307.7

4713

19339

C01DA14

ATC

isosorbide mononitrate; oral

4.0

307.7

1190

2378

ZXD05

NOMESCO Finland

Urgent procedure

2.9

307.7

3016

9342

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

26.2

307.7

490

141

R03BB04

ATC

tiotropium bromide; inhalant

4.4

307.7

1014

1811

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.6

307.7

2562

6426

A10AB04

ATC

insulin lispro; parenteral

129.9

307.7

265

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

1427.6

307.7

368

215

Kela drug reimbursment

Diabetes, non-insulin-treated

411.2

307.7

1731

D64.9

ICD-10 Finland

Anaemia, unspecified

4.8

307.7

1117

1820

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

4.4

307.7

3348

7570

C07AB07

ATC

bisoprolol; oral

3.6

307.7

4211

12525

WX892

NOMESCO Finland

Monitored bed care

5.6

307.7

883

1220

ZX120

NOMESCO Finland

Intravenous

4.8

307.7

1220

2028

E11

ICD-10 Finland

Type 2 diabetes mellitus

19.8

307.7

860

340

A10BK03

ATC

empagliflozin; oral

65.2

307.7

452

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

5.3

307.7

1457

2259

A11CC03

ATC

alfacalcidol; systemic

18.8

307.7

462

184

G56.0

ICD-10 Finland

Carpal tunnel syndrome

14.4

307.7

865

469

A12AA04

ATC

calcium carbonate; oral

25.0

307.7

328

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

52.7

307.7

1723

286

M25.5

ICD-10 Finland

Pain in joint

4.1

307.7

2407

5259

N06AA09

ATC

amitriptyline; systemic

8.0

307.7

771

740

X59

ICD-10 Finland

Exposure to unspecified factor

3.3

307.7

1569

3853

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

981.1

307.7

519

L88

ICPC

Rheumatoid/seropositive arthritis

47.3

307.7

270

SPAT1263

SPAT

Sampling

2.6

307.7

3370

12131

TK800

NOMESCO Finland

Hemodialysis

23.9

307.7

508

160

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.7

307.7

3720

10282

R07.4

ICD-10 Finland

Chest pain, unspecified

3.4

307.7

2353

5985

N17.9

ICD-10 Finland

Acute renal failure, unspecified

10.6

307.7

605

434

A46

ICD-10 Finland

Erysipelas

4.7

307.7

1409

2440

UJF32

NOMESCO Finland

Coloscopy

4.5

307.7

2867

6022

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

27.6

307.7

946

272

N02AX02

ATC

tramadol; systemic, rectal

5.5

307.7

4103

8424

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

51.7

307.7

494

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

3.6

307.7

1536

3438

J01MA02

ATC

ciprofloxacin; systemic

3.9

307.7

4267

11848

SPAT1229

SPAT

Assessment of need for aid

8.9

307.7

594

505

R53

ICD-10 Finland

Malaise and fatigue

3.5

307.7

2116

5213

H02AB06

ATC

prednisolone; systemic

4.3

307.7

4825

13356

C03CA01

ATC

furosemide; systemic

6.5

307.7

3236

5071

S97

ICPC

Chronic ulcer skin

9.4

307.7

597

482

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

9.0

307.7

499

418

M04AA01

ATC

allopurinol; systemic

7.4

307.7

1384

1541

SPAT1222

SPAT

Counselling/guidance promoting independent living

4.2

307.7

1178

2220

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

66.5

307.7

245

T90

ICPC

Diabetes non-insulin dependent

22.0

307.7

1543

595

WX320

NOMESCO Finland

Spinalanesthesy

3.4

307.7

1673

4005

M48.0

ICD-10 Finland

Spinal stenosis

58.4

307.7

835

112

JN3AD

NOMESCO Finland

Abdominal CT examination

5.2

307.7

1394

2176

A28

ICPC

Limited function/disability NOS

6.1

307.7

1428

1913

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

192.1

307.7

362

N06AX21

ATC

duloxetine; oral

6.9

307.7

960

1088

S18

ICPC

Laceration/cut

2.8

307.7

3642

12387

A49.9

ICD-10 Finland

Bacterial infection, unspecified

8.6

307.7

1825

1836

ZXA00

NOMESCO Finland

Right side

3.9

307.7

2236

5039

P01AB01

ATC

metronidazole; oral, rectal

3.6

307.7

4366

13297

L04AX03

ATC

methotrexate; systemic

12.8

307.7

761

459

A10BA02

ATC

metformin; oral

37.0

307.7

1778

423

A10AC01

ATC

insulin (human); parenteral

42.5

307.7

726

132

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.2

307.7

1502

2891

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

110.0

307.7

1367

104

N02AA05

ATC

oxycodone; systemic

4.9

307.7

1761

2999

WX002

NOMESCO Finland

Sedation and analgesia

3.9

307.7

1802

3836

GD1AA

NOMESCO Finland

Thorax X-ray examination

5.8

307.7

4924

10890

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

6.1

307.7

1264

1660

N03AX16

ATC

[U] pregabalin

9.0

307.7

2209

2226

T89

ICPC

Diabetes insulin dependent

80.8

307.7

296

M75.1

ICD-10 Finland

Rotator cuff syndrome

3.8

307.7

1654

3567

M19.0

ICD-10 Finland

Primary arthrosis of other joints

14.6

307.7

629

328

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

6.3

307.7

821

1002

127

Kela drug reimbursment

Transplant complication

35.8

307.7

588

125

J18.9

ICD-10 Finland

Pneumonia, unspecified

5.3

307.7

3121

5762

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

46.7

307.7

304

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.4

307.7

3509

10044

B01AA03

ATC

warfarin; systemic

3.8

307.7

1547

3353

L17

ICPC

Foot/toe symptom/complaint

2.9

307.7

2095

6093

A10AB05

ATC

insulin aspart; parenteral

80.7

307.7

720

N03AX12

ATC

[U] gabapentin; oral

14.5

307.7

1406

807

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

22.0

307.7

347

117

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

6.2

307.7

713

879

M79.6

ICD-10 Finland

Pain in limb

3.8

307.7

3229

8186

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.8

307.7

2261

6801

R06.0

ICD-10 Finland

Dyspnoea

4.5

307.7

2553

5164

K29.3

ICD-10 Finland

Chronic superficial gastritis

11.3

307.7

474

315

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

13.7

307.7

797

453

Z3226

NOMESCO Finland

Physiotherapist

4.6

307.7

1679

3012

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.9

307.7

899

1187

Z01.8

ICD-10 Finland

Other specified special examinations

4.1

307.7

2100

4456

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.5

307.7

1564

3674

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

412.1

307.7

743

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.6

307.7

3560

12693

H02AB04

ATC

methylprednisolone; systemic

4.7

307.7

1631

2893

103

Kela drug reimbursment

Diabetes, insulin-treated

258.7

307.7

1990

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

6.4

307.7

3609

6005

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

242.3

307.7

777

M54.5

ICD-10 Finland

Low back pain

3.6

307.7

2726

6826

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

31.3

307.7

423

101

A02BA02

ATC

ranitidine; systemic

3.3

307.7

1660

4091

A02BC05

ATC

esomeprazole; systemic

3.1

307.7

3636

11385

M13.9

ICD-10 Finland

Arthritis, unspecified

14.2

307.7

572

306

M10.9

ICD-10 Finland

Gout, unspecified

10.5

307.7

568

409

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

8.8

307.7

614

529

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.5

307.7

790

1100

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.3

307.7

1671

4110

Z3231

NOMESCO Finland

Registered nurse

3.1

307.7

2482

7056

N02BF01

ATC

gabapentin; oral

11.3

307.7

558

373

A10BB12

ATC

glimepiride; oral

159.2

307.7

405

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.9

307.7

2047

4544

H02AB07

ATC

prednisone; oral

4.1

307.7

1410

2806

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.9

307.7

1081

1739

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

10.6

307.7

793

581

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

6.9

307.7

665

734

N18.8

ICD-10 Finland

Other chronic renal failure

16.6

307.7

369

165

M01AX05

ATC

glucosamine; oral

4.3

307.7

1053

1905

R4110

NOMESCO Finland

Physiotherapy

3.5

307.7

2512

6435

A10BH01

ATC

sitagliptin; oral

852.4

307.7

561

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.6

307.7

646

739

NF1AA

NOMESCO Finland

Hip X-ray examination

15.7

307.7

703

345

SPAT1262

SPAT

Handing over of treatment supplies

9.0

307.7

1394

1279

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

24.0

307.7

963

318

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.3

307.7

783

492

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

80.7

307.7

543

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.2

307.7

1878

2629

I50.9

ICD-10 Finland

Heart failure, unspecified

5.8

307.7

1292

1804

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

16.5

307.7

450

204

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

8.8

307.7

606

525

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.8

307.7

1059

1234

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.8

307.7

797

1055

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

21.4

307.7

355

123

XF400

NOMESCO Finland

ECG with 12 standard connections

4.3

307.7

1623

3086

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.8

307.7

2053

3096

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

122.4

307.7

727

L01BA01

ATC

methotrexate; systemic

47.8

307.7

323

A10BK01

ATC

dapagliflozin; oral

38.7

307.7

345

A04.5

ICD-10 Finland

Campylobacter enteritis

137.4

307.7

856

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

121.4

307.7

529

B01AC04

ATC

clopidogrel; oral

5.3

307.7

1203

1823

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

44.5

307.7

411

I50.0

ICD-10 Finland

Congestive heart failure

6.2

307.7

681

838

M54.4

ICD-10 Finland

Lumbago with sciatica

5.8

307.7

1266

1771

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.1

307.7

937

1432

A07AA09

ATC

vancomycin; oral

142.8

307.7

1171

A07EC01

ATC

sulfasalazine; oral, rectal

16.7

307.7

665

305

J01MA12

ATC

levofloxacin; systemic

5.0

307.7

2365

4232

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.9

307.7

1181

1370

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

6.4

307.7

736

877

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

10.5

307.7

506

361

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

8.2

307.7

930

892

A10AB01

ATC

insulin (human); parenteral

154.7

307.7

314

A02BC02

ATC

pantoprazole; systemic

4.6

307.7

6464

22370

J45.9

ICD-10 Finland

Asthma, unspecified

3.5

307.7

1603

3758

AA1AD

NOMESCO Finland

CT of head and brain

8.5

307.7

2441

2686

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

7.9

307.7

564

539

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.5

307.7

1666

3880

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

48.3

307.7

263

A41.9

ICD-10 Finland

Sepsis, unspecified

10.4

307.7

588

428

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.3

307.7

1789

4439

R50.9

ICD-10 Finland

Fever, unspecified

5.4

307.7

2089

3391

Z94.0

ICD-10 Finland

Kidney transplant status

43.5

307.7

369

C10AA05

ATC

atorvastatin; oral

2.7

307.7

2935

9659

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

30.3

307.7

507

126

R51.80

ICD-10 Finland

Headache

5.0

307.7

1313

2122

M01AH01

ATC

celecoxib; oral

4.2

307.7

1251

2384

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

4.9

307.7

1067

1726

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

9.4

307.7

1886

1750

L04AX01

ATC

azathioprine; systemic

9.1

307.7

712

601

C08CA01

ATC

amlodipine; oral

3.1

307.7

3008

8889

SPAT1216

SPAT

Assessment of functional ability

4.3

307.7

1088

1981

J01DB01

ATC

cefalexin; oral

3.0

307.7

7281

36820

A06AC01

ATC

ispaghula (psylla seeds); oral

3.2

307.7

2204

5950

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

109.4

307.7

548

R42

ICD-10 Finland

Dizziness and giddiness

3.4

307.7

1715

4138

ACC51

NOMESCO Finland

Release of median nerve

455.7

307.7

427

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.6

307.7

1160

2013

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

20.7

307.7

547

200

L04AD01

ATC

ciclosporin; systemic

21.4

307.7

414

144

I10

ICD-10 Finland

Essential (primary) hypertension

2.8

307.7

4616

17275

P01BA02

ATC

hydroxychloroquine; oral

25.9

307.7

607

179

TPH04

NOMESCO Finland

Cathetrisation of vein

4.8

307.7

2489

4730

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.7

307.7

1038

1715

B03XA02

ATC

darbepoetin alfa; parenteral

15.0

307.7

394

196

B01AB05

ATC

enoxaparin; parenteral

3.4

307.7

2660

6994

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

392

UJF30

NOMESCO Finland

Ileoscopy through colon

4.7

307.7

1221

2072

M16.1

ICD-10 Finland

Other primary coxarthrosis

26.3

307.7

662

193

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.6

307.7

1967

4663

N06AX11

ATC

mirtazapine; oral

2.9

307.7

2820

8598

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

7.1

307.7

1180

1340

L04AD02

ATC

tacrolimus; systemic

32.4

307.7

333

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

123.5

307.7

236

N05CF01

ATC

zopiclone; oral

3.1

307.7

2886

8547

SPAT1254

SPAT

Administration of medicine

4.1

307.7

1250

2448

G47.3

ICD-10 Finland

Sleep apnoea

16.6

307.7

1630

841

Z49.1

ICD-10 Finland

Extracorporeal dialysis

42.5

307.7

350

J01FF01

ATC

clindamycin; systemic

3.8

307.7

2806

6871

Z2446

NOMESCO Finland

Social worker

5.5

307.7

785

1096

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

24.1

307.7

1046

348

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1468.5

307.7

3214

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

16.3

307.7

1216

608

A02BC01

ATC

omeprazole; systemic

3.6

307.7

2554

6392

A10AE05

ATC

insulin detemir; parenteral

207.3

307.7

416

ZXA05

NOMESCO Finland

Left side

3.5

307.7

2048

4919

A06AD11

ATC

lactulose; oral

4.2

307.7

1375

2649

ZXE10

NOMESCO Finland

More than one and less than three hours

2.8

307.7

3011

9660

NE1AA

NOMESCO Finland

Pelvis X-ray examination

12.6

307.7

583

351

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.2

307.7

1706

4407

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

4.1

307.7

1473

2942

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

239.6

307.7

355

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.4

307.1

1396

3309

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

44.9

305.5

239

M01AE03

ATC

ketoprofen; systemic, rectal

2.5

303.7

2808

9830

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

103.8

303.4

213

J01FA06

ATC

roxithromycin; oral

2.4

303.4

3380

12889

SPAT1255

SPAT

Intravenous administration of medicine

5.5

299.2

687

947

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

3.3

299.1

1420

3457

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.9

298.8

417

314

SPAT1153

SPAT

Removal of sutures

2.7

298.6

2245

7092

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

313.7

296.8

340

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

6.3

296.6

594

711

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

69.0

296.3

217

N03AE01

ATC

clonazepam; systemic

7.9

295.4

486

461

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

4.3

294.6

910

1631

A10BH05

ATC

linagliptin; oral

1239.7

294.5

326

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

6.8

294.4

550

609

N18.0

ICD-10 Finland

End-stage renal disease

31.9

294.3

248

JN4AD

NOMESCO Finland

Body CT examination

3.7

294.3

1118

2343

N03AF02

ATC

oxcarbazepine; oral

34.2

293.4

243

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

68.3

293.2

215

C07AB02

ATC

metoprolol; systemic

3.1

292.7

1548

4024

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

100.3

292.6

206

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

21.2

290.6

277

M05BA04

ATC

alendronic acid; oral

5.5

290.2

670

928

N06AB04

ATC

citalopram; systemic

2.9

290.0

1701

4694

M01AH02

ATC

rofecoxib; oral

4.4

290.0

868

1516

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

+∞

289.8

316

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.3

289.8

688

979

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

289.3

4538

19916

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

144.5

288.9

198

N05AH04

ATC

quetiapine; oral

3.2

288.2

1413

3505

R02

ICPC

Shortness of breath/dyspnoea

3.9

287.0

1020

2035

J01AA02

ATC

doxycycline; systemic

2.4

285.9

6577

33762

M01AX17

ATC

nimesulide; oral

3.0

285.2

1661

4562

V03AE01

ATC

polystyrene sulfonate; oral

29.0

283.5

245

C09AA05

ATC

ramipril; oral

2.8

283.3

1807

5219

A10BB01

ATC

glibenclamide; oral

91.7

283.1

201

XW000

NOMESCO Finland

Bone marrow biopsy

6.7

282.4

536

604

N05CD07

ATC

temazepam; oral

3.8

281.7

1052

2175

C09AA02

ATC

enalapril; systemic

3.1

278.0

1471

3817

M70.6

ICD-10 Finland

Trochanteric bursitis

4.7

276.9

767

1254

137

Kela drug reimbursment

Uraemia requiring dialysis

41.2

276.7

220

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

276.0

301

L04AA01

ATC

[U] ciclosporin

27.0

275.6

243

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.6

275.4

772

1275

M01AH05

ATC

etoricoxib; oral

2.2

273.4

4465

19773

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

5.4

271.7

639

900

M02AA07

ATC

piroxicam; topical

2.4

270.5

2569

9030

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

3.5

270.2

1151

2603

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.2

267.5

1284

3135

ZXE00

NOMESCO Finland

One hour or less

2.3

266.1

3221

12582

TGC00

NOMESCO Finland

Bronchial lavation

10.7

265.7

351

242

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

6.7

265.7

504

567

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

10.6

264.4

351

244

ZXD10

NOMESCO Finland

Scheduled procedure

2.3

264.1

3063

11741

D11

ICPC

Diarrhoea

3.4

263.6

1144

2617

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.2

263.4

641

932

A01

ICPC

Pain general/multiple sites

4.9

263.1

679

1042

K59.1

ICD-10 Finland

Functional diarrhoea

5.7

262.6

579

765

H02AB09

ATC

hydrocortisone; systemic

10.1

257.5

354

260

L13

ICPC

Hip symptom/complaint

3.5

257.2

1079

2412

N04BC05

ATC

pramipexole; oral

6.7

255.9

480

533

N05BA01

ATC

diazepam; systemic, rectal

3.5

255.6

1070

2388

C02AC05

ATC

moxonidine; oral

9.2

255.4

374

302

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.6

254.6

1892

5889

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.9

253.8

1471

4009

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

44.0

253.4

199

J01DA01

ATC

[U] cefalexin

2.1

251.0

5179

24830

M01AC06

ATC

meloxicam; systemic, rectal

2.4

249.9

2424

8557

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

7.0

248.8

448

474

SPAT1301

SPAT

No procedures

2.4

248.3

2305

7973

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

12.8

248.1

295

169

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

13.8

246.4

282

150

TAB00

NOMESCO Finland

Lumbar puncture

9.8

246.2

344

259

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

16.0

245.8

262

120

M03BX02

ATC

tizanidine; oral

2.1

245.5

4743

22108

R4120

NOMESCO Finland

Occupational therapy

7.4

245.2

423

425

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

243.7

266

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

7.4

243.0

420

423

M43.1

ICD-10 Finland

Spondylolisthesis

25.3

242.6

218

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

242.6

1119

2656

L15

ICPC

Knee symptom/complaint

2.8

242.4

1483

4158

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.5

242.0

1024

2298

M03BC01

ATC

orphenadrine (citrate); systemic

2.7

241.8

1613

4738

N03AX14

ATC

levetiracetam; systemic

26.7

239.8

212

WZC00

NOMESCO Finland

Treatment plan or consultation

2.2

239.6

3065

12141

GD1AD

NOMESCO Finland

Thorax CT examination

5.1

239.6

590

866

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

239.1

261

M47.9

ICD-10 Finland

Spondylosis, unspecified

36.3

237.5

194

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.3

237.3

724

1279

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.0

235.7

491

611

A07EC02

ATC

mesalazine; oral, rectal

4.3

235.4

725

1290

C08CA02

ATC

felodipine; oral

4.2

235.0

743

1350

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

14.8

234.6

259

128

A10AA02, ,

ATC

224.5

234.2

273

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

11.6

233.5

293

185

N06AX16

ATC

venlafaxine; oral

3.3

233.4

1070

2527

M20.1

ICD-10 Finland

Hallux valgus (acquired)

7.8

233.0

384

364

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

246.7

232.9

270

G40.9

ICD-10 Finland

Epilepsy, unspecified

482.4

232.8

263

Z49.0

ICD-10 Finland

Preparatory care for dialysis

32.9

232.1

194

01102

ICD-8 Finland

Pulmonary tuberculosis, Non cavernosa

+∞

229.9

251

B05DA

ATC

Isotonic solutions

42.5

229.0

181

Z50.1

ICD-10 Finland

Other physical therapy

7.5

228.3

391

389

N03AG01

ATC

valproic acid; systemic, rectal

6.0

227.3

472

585

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

10.0

226.9

312

229

E86

ICD-10 Finland

Volume depletion

11.2

226.7

291

191

A07EA06

ATC

budesonide; oral, local oral

5.6

225.8

506

678

C08CA13

ATC

lercanidipine; oral

3.4

224.8

967

2190

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

20.3

224.5

217

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

45.5

224.3

175

N03AF01

ATC

carbamazepine; oral, rectal

8.0

224.2

362

334

Z49.2

ICD-10 Finland

Other dialysis

46.9

224.2

174

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

37.6

223.4

181

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

222.2

1699

5330

B01AF01

ATC

rivaroxaban; oral

4.1

222.1

722

1339

E66.01

ICD-10 Finland

Obesity due to excess calories

4.9

222.1

572

874

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1743.5

222.0

245

G04CA02

ATC

tamsulosin; oral

2.5

222.0

1848

6040

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

28.1

221.7

193

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

5.7

221.6

484

632

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.5

220.9

638

1076

R5110, ,

SPAT

6.6

220.9

418

468

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

220.5

2171

7657

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

22.1

219.6

206

A04

ICPC

Weakness/tiredness general

3.1

219.3

1109

2778

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

93.8

218.7

155

NA1AD

NOMESCO Finland

Cervical spine CT examination

8.6

218.6

333

284

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

25.8

218.6

195

M01AE02

ATC

naproxen; oral, rectal

2.0

218.1

4276

19748

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.3

218.1

1007

2385

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

362.8

217.5

248

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

21.2

216.3

206

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.9

216.1

561

863

TKC20

NOMESCO Finland

Catheterisation of bladder

4.3

215.1

648

1131

XG466

NOMESCO Finland

Sleep oxymetry

14.0

214.6

244

128

V03AE02

ATC

sevelamer; oral

91.9

214.1

152

M45

ICD-10 Finland

Ankylosing spondylitis

79.9

213.8

154

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.8

213.7

568

892

M54.1

ICD-10 Finland

Radiculopathy

12.7

213.6

255

147

E66.8

ICD-10 Finland

Other obesity

6.9

213.1

387

413

207

Kela drug reimbursment

Chronic arrhythmias

3.2

213.1

1036

2532

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1668.5

212.8

235

H25.1

ICD-10 Finland

Senile nuclear cataract

2.5

212.8

1783

5834

A07AA02

ATC

nystatin; oral

4.7

212.2

574

915

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.3

211.4

502

711

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.7

211.3

808

1687

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.7

209.9

565

897

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

65.8

208.9

154

K92.1

ICD-10 Finland

Melaena

5.0

207.9

527

793

M79.7

ICD-10 Finland

Fibromyalgia

17.9

207.9

211

M79.1

ICD-10 Finland

Myalgia

3.2

207.5

964

2289

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

206.0

5839

30470

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

34.3

205.5

170

B01AF02

ATC

apixaban; oral

3.5

205.5

828

1791

W19

ICD-10 Finland

Unspecified fall

3.7

202.5

742

1502

A10BJ06

ATC

semaglutide; parenteral

+∞

202.3

221

G20

ICD-10 Finland

Parkinson disease

103.0

202.0

142

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

8.7

201.9

307

261

M01AB05

ATC

diclofenac; systemic, rectal

2.0

201.9

4979

24683

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

13.0

201.9

238

134

N30.0

ICD-10 Finland

Acute cystitis

2.8

201.0

1253

3526

M54.3

ICD-10 Finland

Sciatica

7.2

200.4

353

363

OAB50, ,

SPAT

8.6

200.2

305

260

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

4.6

200.0

556

907

ZXA10

NOMESCO Finland

Bilateral

2.6

199.9

1389

4137

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.9

199.5

683

1315

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

+∞

199.5

218

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

5.9

198.7

417

522

L90

ICPC

Osteoarthrosis of knee

8.5

198.6

306

265

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

31.9

198.4

167

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

198.2

3123

13207

E66.00

ICD-10 Finland

Metabolic syndrome

7.4

197.4

339

338

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

197.3

982

2430

B05DB

ATC

Hypertonic solutions

39.6

197.1

158

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.6

197.0

436

576

WW500

NOMESCO Finland

Blood transfusion

4.6

196.8

547

892

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.0

196.7

491

728

N19

ICD-10 Finland

Unspecified kidney failure

7.5

195.3

333

329

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

13.1

194.4

228

127

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

14.9

194.3

214

105

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

37.0

194.3

158

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

27.9

193.8

169

Z2221

NOMESCO Finland

Medical doctor

2.2

193.6

2321

8828

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.5

193.6

1500

4710

WX872

NOMESCO Finland

Intensive care

4.7

193.1

520

825

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.5

192.9

370

420

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

7.8

192.2

315

296

J02AC01

ATC

fluconazole; systemic

2.0

192.1

3115

13280

A10BJ02

ATC

liraglutide; parenteral

55.3

192.0

145

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

4.9

192.0

491

744

NHQ40

NOMESCO Finland

Amputation of toe

26.7

191.3

169

M47.82

ICD-10 Finland

Other spondylosis, cervical region

16.9

191.3

199

XF600

NOMESCO Finland

Bloodpressure measurement

4.5

191.0

543

902

XF402

NOMESCO Finland

ECG with work load test

3.5

190.9

775

1683

L08

ICPC

Shoulder symptom/complaint

2.6

189.6

1405

4313

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.6

189.6

319

310

Z3229

NOMESCO Finland

Other healthcare associate professional

3.7

189.3

699

1421

A10AE06

ATC

insulin degludec; parenteral

518.1

188.9

213

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

10.4

188.8

253

178

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

6.0

188.7

388

475

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

3.2

188.5

891

2134

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

188.0

1643

5452

P20

ICPC

Memory disturbance

3.7

187.6

697

1423

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

9.5

187.2

266

205

A10AA01, ,

ATC

229.3

187.2

218

E0000UV, ,

ATC

2.0

186.6

3340

14713

R55

ICD-10 Finland

Syncope and collapse

3.3

186.3

815

1858

L86

ICPC

Back syndrome with radiating pain

6.2

186.0

376

452

AN1

Coronary angiography

3.6

184.9

726

1540

M10.0

ICD-10 Finland

Idiopathic gout

10.4

184.7

248

175

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

5.7

184.6

403

525

SPAT1104

SPAT

Monitoring of emergency patient

4.4

184.5

535

903

M01AB55

ATC

diclofenac, combinations; oral

5.4

184.4

422

576

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1437.1

184.4

204

UJD02

NOMESCO Finland

Gastroscopy

5.1

184.4

456

670

A41.8

ICD-10 Finland

Other specified sepsis

9.4

184.3

263

204

WX882

NOMESCO Finland

High dependency care

7.3

184.2

318

319

J45.1

ICD-10 Finland

Nonallergic asthma

4.1

184.1

594

1092

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.5

184.0

760

1668

J01FA09

ATC

clarithromycin; systemic

2.1

183.9

2534

10143

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.7

183.7

676

1370

XA800

NOMESCO Finland

Neuropsychological investigation

9.2

183.6

266

211

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

25.0

183.1

165

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

500.7

182.5

206

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

24.1

182.2

166

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.0

182.1

613

1164

C09CA01

ATC

losartan; oral

2.3

181.9

1737

5989

196

Kela drug reimbursment

Paricalcitol and cinacalcet

79.1

181.6

131

R31

ICD-10 Finland

Unspecified haematuria

3.2

181.5

854

2038

J01EA01

ATC

trimethoprim; systemic

2.2

181.4

2013

7394

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.1

181.2

917

2287

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.3

180.9

1829

6461

M54.2

ICD-10 Finland

Cervicalgia

4.7

180.8

493

790

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.8

180.0

637

1255

R52.2

ICD-10 Finland

Other chronic pain

9.6

179.9

253

192

K59.09

ICD-10 Finland

Constipation, unspecified

4.3

179.5

533

917

X58

ICD-10 Finland

Exposure to other specified factors

2.8

178.9

1068

2926

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

91.9

178.8

127

R52.9

ICD-10 Finland

Pain, unspecified

3.6

178.8

685

1428

R13

ICD-10 Finland

Dysphagia

4.3

178.3

534

925

B99

ICD-10 Finland

Other and unspecified infectious diseases

8.9

177.7

264

217

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

177.6

2244

8671

SPAT1260

SPAT

Consultation of another employee

2.6

177.3

1236

3673

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

91.2

177.3

126

XG410

NOMESCO Finland

Flow-volume spirometry

6.0

177.2

364

445

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.0

176.8

952

2461

C10AX09

ATC

ezetimibe; oral

3.0

176.5

950

2455

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

8.2

175.9

279

251

B01AB10

ATC

tinzaparin; parenteral

3.2

175.6

834

2000

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

175.6

192

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.4

174.4

724

1593

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

14.1

174.3

197

102

D07AC01

ATC

betamethasone; topical

2.0

174.1

2776

11681

L89

ICD-10 Finland

Decubitus ulcer and pressure area

15.6

174.0

187

C10AA03

ATC

pravastatin; oral

4.4

172.8

499

839

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.6

172.3

1234

3713

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

31.9

172.2

145

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

50.3

172.2

132

M09AX01

ATC

hyaluronic acid; parenteral

10.3

171.9

232

165

R33

ICD-10 Finland

Retention of urine

3.5

171.7

686

1471

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

5.3

171.0

401

560

SPAT1097

SPAT

Recording of ECG

2.9

170.7

964

2558

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

31.6

170.7

144

WZC30

NOMESCO Finland

Teaching

2.6

170.6

1253

3817

G56.2

ICD-10 Finland

Lesion of ulnar nerve

14.1

170.2

192

WW200

NOMESCO Finland

Immunization

5.6

170.1

375

493

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.8

169.7

236

176

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

3.1

169.6

846

2089

SPAT1310

SPAT

Counselling related to known health issue

2.1

169.5

2165

8380

L04AA13

ATC

[U] leflunomide

207.2

169.1

198

N39.4

ICD-10 Finland

Other specified urinary incontinence

4.0

168.7

554

1031

A10BD07

ATC

metformin and sitagliptin; systemic

684.5

167.8

188

M81.9

ICD-10 Finland

Osteoporosis, unspecified

7.5

167.7

284

278

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

167.3

183

D01

ICPC

Abdominal pain/cramps general

2.9

166.9

937

2477

H03BB01

ATC

carbimazole; oral

17.3

166.1

171

J01CA04

ATC

amoxicillin; systemic

2.0

165.7

6878

39328

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

165.5

181

K29.6

ICD-10 Finland

Other gastritis

14.3

165.2

185

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

3.6

165.0

633

1319

NH3EA

NOMESCO Finland

Feet X-ray examination with load

78.2

164.8

119

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

44.1

163.1

128

A03FA01

ATC

metoclopramide; systemic, rectal

2.1

163.1

1951

7349

JN4BD

NOMESCO Finland

Extensive body CT

2.8

163.0

1011

2821

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

18.2

161.9

163

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

161.8

177

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

83.9

161.8

116

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

58.4

161.5

121

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.0

161.2

830

2086

SPAT1249

SPAT

Treatment-related counselling outside office

2.0

160.6

2728

11673

WX780

NOMESCO Finland

Remote monitoring CPAP

441.0

160.6

182

G43.9

ICD-10 Finland

Migraine, unspecified

5.8

160.6

342

434

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.0

160.5

529

987

B03XA01

ATC

erythropoietin; parenteral

16.5

160.1

168

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

43.4

160.1

126

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.1

159.8

776

1883

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

+∞

159.1

174

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

4.2

159.0

492

874

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

7.4

158.9

273

272

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

158.4

2162

8551

C03AA03

ATC

hydrochlorothiazide; oral

3.8

158.3

565

1118

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

11.8

158.0

196

121

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.9

157.8

286

304

G51.0

ICD-10 Finland

Bell palsy

29.6

157.4

135

212

Kela drug reimbursment

Gout

+∞

157.2

172

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.7

157.1

237

199

TQW11

NOMESCO Finland

Vacuum treatment of wound

9.3

156.6

226

178

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

156.5

3013

13424

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

7.4

156.3

266

262

K51.5

ICD-10 Finland

Left sided colitis

4.8

156.2

407

626

C07AG02

ATC

carvedilol; oral

4.4

156.1

456

773

L04AB04

ATC

adalimumab; parenteral

11.9

155.9

192

117

XF404

NOMESCO Finland

Ambulatory ECG

3.5

155.6

630

1361

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

190.7

155.5

183

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

155.4

170

NBG10

NOMESCO Finland

Acromioplastia

35.4

154.6

127

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.4

154.5

638

1396

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.5

154.3

430

701

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

153.6

1872

7083

01107

ICD-8 Finland

Pulmonary tuberculosis, Suspecta

+∞

153.6

168

E87.5

ICD-10 Finland

Hyperkalaemia

12.9

153.3

181

102

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.7

153.2

415

660

A29

ICPC

General symptom/complaint other

2.8

153.2

905

2456

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

625.1

153.2

172

UJF92

NOMESCO Finland

Capsular endoscopy

7.5

153.1

258

251

A12BA01

ATC

potassium chloride; oral

5.6

153.0

338

445

R20.2

ICD-10 Finland

Paraesthesia of skin

4.2

152.3

472

839

R05

ICPC

Cough

2.2

152.2

1704

6233

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.8

152.2

916

2511

A03

ICPC

Fever

2.3

152.0

1405

4743

I50.1

ICD-10 Finland

Left ventricular failure

4.9

151.9

388

586

R05FB02

ATC

cough suppressants and expectorants; systemic

1.9

151.0

2732

11896

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

313.5

150.8

173

R07.3

ICD-10 Finland

Other chest pain

3.2

150.0

706

1679

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

3.8

149.1

530

1045

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.0

148.6

2420

10159

G30.1

ICD-10 Finland

Alzheimer disease with late onset

8.6

148.5

226

192

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

28.3

148.5

129

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.0

148.3

493

925

H05BX01

ATC

cinacalcet; oral

37.7

148.2

120

R06AE07

ATC

cetirizine; oral

1.8

147.5

3436

16191

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

3.4

147.3

630

1410

R60.9

ICD-10 Finland

Oedema, unspecified

4.7

147.2

395

623

NG2AA

NOMESCO Finland

Patella X-ray examination

21.1

147.1

140

WX723

NOMESCO Finland

CPAP therapy

159.2

147.0

175

SPAT1053

SPAT

Memory test

3.0

146.7

746

1858

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.0

146.6

744

1851

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.2

146.5

230

204

M50.3

ICD-10 Finland

Other cervical disc degeneration

23.7

146.3

134

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

8.6

146.3

223

190

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.3

146.1

628

1410

ZX108

NOMESCO Finland

Inhalation

16.1

146.1

155

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

595.4

145.9

164

N06DX01

ATC

memantine; oral

6.1

145.6

295

355

N06AB10

ATC

escitalopram; oral

2.2

145.6

1508

5336

N03AX09

ATC

lamotrigine; oral

5.2

145.5

346

489

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

35.9

145.3

119

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

37.1

145.2

118

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

15.4

145.2

157

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1201.0

145.0

161

L89

ICPC

Osteoarthrosis of hip

14.7

144.8

160

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.8

144.3

876

2410

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.9

144.2

483

911

XKD00

NOMESCO Finland

Uroflowmetry

2.4

143.9

1151

3635

R03BA05

ATC

fluticasone; inhalant

2.3

143.6

1413

4891

R05

ICD-10 Finland

Cough

2.2

143.3

1524

5448

N80.1

ICD-10 Finland

Endometriosis of ovary

59.4

143.1

107

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.6

143.0

998

2950

N18

ICPC

Paralysis/weakness

36.5

142.2

116

M20.2

ICD-10 Finland

Hallux rigidus

20.3

141.8

137

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.6

141.7

546

1139

H03AA01

ATC

levothyroxine sodium; systemic

2.2

141.1

1539

5555

Z71.8

ICD-10 Finland

Other specified counselling

1.9

141.0

2257

9394

L12

ICPC

Hand/finger symptom/complaint

2.5

140.8

1063

3264

B01AC07

ATC

dipyridamole; systemic

6.1

140.8

284

340

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.0

140.5

348

511

SPAT1325

SPAT

Vaccination

1.9

140.4

2326

9792

H25.8

ICD-10 Finland

Other senile cataract

3.0

140.3

712

1770

I20.09

ICD-10 Finland

Unstable angina

4.4

140.1

403

674

WX704

NOMESCO Finland

Intubation

3.2

140.0

659

1566

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

11.0

140.0

181

120

C10AC01

ATC

colestyramine; oral

6.6

139.6

263

292

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

12.3

139.4

169

100

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

29.7

138.8

119

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1141.9

138.6

154

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.6

138.1

524

1081

SPAT1231

SPAT

Assessment of adjustments needed in living environment

18.0

137.4

139

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

39.7

137.3

110

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

39.7

137.3

110

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

+∞

137.1

150

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

23.8

136.7

125

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

7.9

136.6

221

204

A01AB09

ATC

miconazole; local oral

3.1

136.5

682

1679

J05AB01

ATC

aciclovir; systemic

2.1

136.5

1724

6580

SPAT1234

SPAT

Support of social functional capacity

4.9

136.5

344

513

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

12.2

136.4

166

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

+∞

136.1

149

I20.99

ICD-10 Finland

Angina pectoris, unspecified

4.1

135.9

429

773

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

23.2

135.6

125

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.0

135.6

713

1809

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

65.6

135.5

100

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

+∞

135.2

148

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

134.6

2240

9424

N80.0

ICD-10 Finland

Endometriosis of uterus

36.1

134.6

110

TK810

NOMESCO Finland

Hemofiltration

22.6

134.5

125

K90

ICPC

Stroke/cerebrovascular accident

191.7

134.3

158

N17.8

ICD-10 Finland

Other acute renal failure

11.8

134.1

166

102

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

56.1

133.9

101

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

12.7

133.1

158

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

4.4

132.7

380

633

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

16.7

132.2

138

G04BD12

ATC

mirabegron; oral

3.0

132.1

664

1640

R03AK07

ATC

formoterol and budesonide; inhalant

2.1

131.7

1587

5942

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.1

131.7

209

188

B03BA03

ATC

hydroxocobalamin; parenteral

4.1

131.7

417

753

J01FA10

ATC

azithromycin; systemic

1.7

131.6

4561

23875

N05CF02

ATC

zolpidem; oral

2.3

131.2

1255

4281

R03DC03

ATC

montelukast; oral

2.3

131.1

1176

3902

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.5

130.9

510

1071

M22.4

ICD-10 Finland

Chondromalacia patellae

14.6

130.8

145

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.7

130.8

473

943

A08

ICPC

Swelling

4.8

130.7

336

510

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

130.6

143

M54.6

ICD-10 Finland

Pain in thoracic spine

3.9

130.2

447

858

SPAT1252

SPAT

Overall medication plan or its review

3.9

130.1

433

812

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

14.8

129.9

143

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

129.7

142

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

45.6

129.4

101

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

54.4

129.4

1220

FHL

Arthroscopy

8.3

129.2

202

178

WX204

NOMESCO Finland

Axillary plexus blockaced

6.5

129.2

245

274

N06AA10

ATC

nortriptyline; systemic

12.5

129.2

155

N06AB03

ATC

fluoxetine; oral

2.6

128.9

879

2563

R96

ICPC

Asthma

3.0

128.8

643

1581

H3603, E103,

ICD-10 Finland

+∞

128.8

141

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.3

128.6

566

1288

A02BDXX, ,

ATC

4.9

128.3

324

484

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

5.1

128.2

309

442

TK820

NOMESCO Finland

Peritoneal dialysis

39.1

128.2

103

K51.8

ICD-10 Finland

Other ulcerative colitis

7.5

128.1

215

208

E87.6

ICD-10 Finland

Hypokalaemia

5.4

128.0

293

399

R03BA01

ATC

beclometasone; inhalant

2.4

128.0

1052

3354

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

1041.8

127.6

142

WX402

NOMESCO Finland

General anaesthesia

2.0

127.5

1678

6487

0084F

ICD-9 Finland

Intestinal infections due to other organisms, Other specified bacteria[ENTERITIS CLOSTRIDIUM DIFFICILE]

+∞

127.0

139

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

37.2

126.8

103

V03AE03

ATC

lanthanum carbonate; oral

67.1

126.4

C08CA05

ATC

nifedipine; systemic

3.7

126.3

454

901

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.0

126.1

413

765

J46

ICD-10 Finland

Status asthmaticus

7.0

125.7

224

233

C01AA05

ATC

digoxin; systemic

3.2

125.6

585

1379

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

125.6

3841

19339

K29.7

ICD-10 Finland

Gastritis, unspecified

5.2

125.5

299

423

K30

ICD-10 Finland

Functional dyspepsia

2.6

125.3

822

2349

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.7

125.2

813

2311

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

22.7

124.9

116

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

21.0

124.8

119

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.6

124.7

339

540

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.6

124.6

464

944

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

124.4

671

1725

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

10.9

124.3

161

107

R03BA02

ATC

budesonide; inhalant

2.2

124.1

1344

4818

R4190

NOMESCO Finland

Nutritional therapy

4.0

123.7

397

724

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

38.0

123.7

100

C10AA04

ATC

fluvastatin; oral

3.5

123.6

499

1073

I95.1

ICD-10 Finland

Orthostatic hypotension

6.9

123.5

224

238

H04AA01

ATC

glucagon; nasal, parenteral

121.0

123.4

150

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

15.7

123.1

132

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

122.9

1503

5647

J96.1

ICD-10 Finland

Chronic respiratory failure

6.7

122.8

228

249

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

122.5

3005

14192

RD210, ,

NOMESCO Finland

8.2

122.4

193

172

J01CF05

ATC

flucloxacillin; systemic

3.5

121.8

487

1040

A99

ICPC

Disease/condition unspecnature/site

2.9

121.5

652

1671

SPAT1215

SPAT

Assessment of need for medical rehabilitation

5.4

121.3

278

379

N03AX11

ATC

topiramate; oral

10.8

121.3

158

106

M02AA10

ATC

ketoprofen; topical

2.4

121.0

983

3113

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

21.7

120.9

114

J20

ICD-10 Finland

Acute bronchitis

2.8

120.8

718

1947

G72.8

ICD-10 Finland

Other specified myopathies

492.0

120.4

136

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.8

119.8

311

476

N30.9

ICD-10 Finland

Cystitis, unspecified

3.5

119.8

477

1016

A03FA02

ATC

cisapride; oral, rectal

3.3

119.6

529

1207

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.2

118.8

541

1257

R35

ICD-10 Finland

Polyuria

3.5

118.7

459

958

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

11.3

118.4

150

M03BX01

ATC

baclofen; systemic

16.8

118.3

123

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.2

118.2

359

627

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.7

118.0

314

491

M01AB01

ATC

indometacin; systemic, rectal

3.5

117.9

465

984

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

117.8

129

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

117.8

129

Z02.7

ICD-10 Finland

Issue of medical certificate

3.4

117.6

497

1101

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.3

117.3

344

584

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.5

117.1

461

974

N06AX03

ATC

mianserin; oral

4.2

116.9

357

626

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.9

116.8

398

759

WZA90

NOMESCO Finland

Other medical or dental certificate

2.0

116.8

1606

6288

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.8

116.6

410

800

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.7

116.6

738

2068

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.9

116.2

647

1692

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

23.9

116.2

106

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.5

116.1

451

944

M05BA07

ATC

risedronic acid; oral

7.5

116.0

196

191

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

39.5

115.9

321

Kela drug reimbursment

Paricalcitol and cinacalcet

39.5

115.9

N02AJ13

ATC

tramadol and paracetamol; systemic

13.6

115.8

133

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.8

115.7

403

781

NG1DA

NOMESCO Finland

X-ray of knees

52.9

115.6

ZXD20

NOMESCO Finland

Day surgery

2.5

115.3

877

2691

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.6

115.1

442

918

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

142.9

115.1

138

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

+∞

115.1

126

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

10.9

115.0

149

D06

ICPC

Abdominal pain localized other

2.9

114.6

627

1623

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

4.2

114.6

345

598

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

114.5

1857

7690

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.4

114.4

462

993

R4110, ,

SPAT

3.4

114.3

481

1062

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

41.0

114.3

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

22.1

114.2

107

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

20.4

114.2

110

R06.5

ICD-10 Finland

Mouth breathing

3.3

114.0

503

1145

R01AD09

ATC

mometasone; nasal

1.7

114.0

3301

16254

SPAT1211

SPAT

Application of soft bandage

3.0

113.8

563

1375

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

4.0

113.8

373

691

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.3

113.7

486

1084

B01AB04

ATC

dalteparin; parenteral

3.7

113.3

408

810

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

113.2

124

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

193.1

113.2

133

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

6.3

113.1

220

253

XA402

NOMESCO Finland

ENMG

16.2

112.8

119

R03AC12

ATC

salmeterol; inhalant

3.7

112.8

409

816

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

565

580

7.35

322.70

4.1

2.1

9.90

10.46

g/l

1.19

508

518

(3023183) Ammonium ion [Moles/volume] in Plasma

502

446

8.44

320.88

3.7

2.7

33.27

39.31

umol/l

2.69

465

414

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

515

477

8.11

319.06

1.9

1.2

1.15

1.17

g/l

0.36

487

445

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

418

285

10.92

318.99

1.9

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

504

461

8.20

315.18

1.9

1.2

0.23

0.24

g/l

0.66

475

426

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

424

302

10.46

314.95

2.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

424

302

10.46

314.95

2.3

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

445

342

9.71

314.75

5.5

4.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

423

301

10.47

314.39

2.3

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

400

268

11.10

308.40

1.7

1.3

—

(3025941) Bacteria identified in Stool by Culture

1379

1800

6.26

307.65

1.6

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

322

25.31

307.65

34.0

28.2

117.50

137.33

ug/l

1.83

270

(3023520) Reticulocytes [#/volume] in Blood

1445

1921

6.18

307.65

3.9

2.7

70.41

66.54

e9/l

2.34

1110

1395

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

567

464

9.23

307.65

5.5

4.0

52.85

35.66

mg/l

1.14

462

394

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1141

1019

8.98

307.65

6.7

4.1

5.07

5.08

kpa

0.06

1095

957

(3001604) Monocytes [#/volume] in Blood

5539

16198

4.62

307.65

11.4

4.5

0.62

0.57

e9/l

9.73

5024

13754

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

515

420

9.21

307.65

2.7

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2738

1653

16.41

307.65

2.9

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

617

612

7.64

307.65

4.2

2.1

7.43

7.03

g/l

4.25

565

555

(3021601) Nitrite [Presence] in Urine by Test strip

4494

16973

2.74

307.65

7.6

3.4

0.00

estimate

1.60

895

2898

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

749

493

11.72

307.65

2.0

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6110

23812

3.47

307.65

7.1

3.0

895.14

611.43

e6/l

0.19

109

289

(3030467) Casts [#/volume] in Urine by Automated count

3116

8515

3.44

307.65

5.7

2.5

0.39

0.56

e6/l

2.51

2574

5970

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

868

744

9.09

307.65

4.2

2.4

—

(3000494) Fungus identified in Specimen by Culture

1584

3645

3.54

307.65

2.1

1.3

—

(3021589) Normoblasts [#/volume] in Blood

4168

16334

2.50

307.65

19.8

6.7

0.00

e9/l

0.60

3499

13021

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2228

3452

5.76

307.65

4.7

1.9

21.56

24.52

12.44

1928

3010

(3014111) Lactate [Moles/volume] in Serum or Plasma

1393

2299

4.92

307.65

11.2

6.8

1.37

1.27

mmol/l

1.72

1369

2231

(3042936) Bacteria identified in Isolate by Culture

2272

3596

5.66

307.65

3.1

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2671

5076

4.88

307.65

5.3

2.0

21.24

7.64

mg/mmol

12.29

1874

2658

(3012544) pH of Venous blood

1699

2206

6.52

307.65

8.6

3.3

7.38

—

(3044640) Blood type and Crossmatch panel - Blood

3477

10995

3.02

307.65

4.4

2.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

647

554

8.89

307.65

3.0

2.1

428.12

399.12

ug/l

0.12

604

527

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2532

4553

5.10

307.65

7.2

3.9

0.80

0.83

mmol/l

23.58

2411

4334

(3023368) Bacteria identified in Blood by Culture

4212

7189

6.87

307.65

8.2

3.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

433

299

10.80

307.65

2.3

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4851

12913

4.56

307.65

14.3

4.9

1.21

mmol/l

6.53

4549

11705

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2004

3335

5.21

307.65

6.8

4.9

248.64

253.02

u/l

0.34

1908

3197

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

636

715

6.75

307.65

1.5

1.3

—

(3022313) Gas panel - Capillary blood

797

728

8.46

307.65

7.1

4.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1037

1014

8.10

307.65

3.8

2.5

—

(3012516) Albumin [Mass/volume] in Urine

2566

4749

4.96

307.65

4.7

1.8

1009.30

478.10

mg/l

2.98

1840

2478

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1630

2122

6.45

307.65

8.8

3.2

5.78

5.79

kpa

0.12

1573

2059

(3009445) Proteinase 3 Ab [Units/volume] in Serum

772

769

7.73

307.65

1.7

1.2

9.51

9.06

u/ml

0.02

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2634

3813

6.51

307.65

2.9

1.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1627

2677

5.06

307.65

10.9

7.3

11.70

13.83

kpa

32.42

1543

2556

(3022217) INR in Platelet poor plasma by Coagulation assay

4958

12806

4.82

307.65

18.8

9.9

1.23

inr

0.07

1404

3616

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1893

2469

6.63

307.65

2.5

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5790

17953

4.51

307.65

10.1

3.6

6.79

6.14

mmol/l

86.89

5560

16415

(3009508) Creatinine [Moles/volume] in Urine

2757

5955

4.29

307.65

4.6

1.8

6.98

8.38

mmol/l

32.38

2425

5194

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2725

8343

2.89

307.65

4.1

2.0

—

(3006315) Basophils [#/volume] in Blood

5547

16228

4.62

307.65

11.4

4.5

0.04

e9/l

0.05

5037

13760

(3000475) Leukocytes [#/volume] in Synovial fluid

333

28.00

307.65

1.8

1.2

11881.02

25040.07

e6/l

0.50

255

(3005719) IgG [Mass/volume] in Serum or Plasma

1476

1694

7.22

307.65

4.0

2.5

9.89

10.78

g/l

6.66

1380

1553

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7099

28147

4.50

307.65

16.5

6.5

82.68

80.06

u/l

3.18

6860

26339

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

671

557

9.20

307.65

2.8

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

693

638

8.31

307.65

7.6

4.7

24.60

24.72

mmol/l

0.34

655

591

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1309

2065

5.11

307.65

2.7

2.8

352.55

396.00

nmol/l

7.18

1220

1927

(3034860) Kappa light chains.free [Mass/volume] in Serum

570

466

9.24

307.65

5.4

4.0

62.68

47.46

mg/l

1.28

468

397

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

662

690

7.30

307.65

2.0

1.4

24.81

23.53

u/ml

0.06

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1334

2259

4.76

307.65

12.4

7.8

115.54

121.09

g/l

13.53

1296

2197

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

677

575

8.99

307.65

1.7

1.5

8.70

3.86

iu/ml

0.26

167

126

(3011397) Hemoglobin [Presence] in Urine by Test strip

2299

7029

2.78

307.65

5.0

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1022

978

8.27

307.65

2.2

1.6

1.54

1.44

g/l

1.65

907

825

(40768797) Stomach Pathology biopsy report

1816

3980

3.81

307.65

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2019

5267

3.23

307.65

1.8

1.4

22862572.95

25430996.90

pmol/l

0.08

1719

4471

(3035350) Ketones [Presence] in Urine by Test strip

4500

16802

2.78

307.65

5.6

2.4

0.00

estimate

1.08

927

2984

(3024522) Salmonella sp identified in Specimen by Organism specific culture

432

301

10.70

307.65

2.3

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1259

1534

6.63

307.65

4.0

3.0

64.40

65.86

g/l

5.45

1162

1414

(3004119) Hemoglobin [Mass/volume] in Venous blood

962

1304

5.77

307.65

7.8

2.9

118.82

130.19

g/l

28.06

937

1280

(3009343) pH of Capillary blood

1126

1014

8.89

307.65

6.7

4.1

7.41

7.42

1.07

147

118

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3214

6716

4.71

307.65

3.0

1.9

3.03

2.85

mg/l

2.98

2848

5632

(3015736) pH of Urine

3793

13462

2.72

307.65

4.8

2.3

5.82

5.95

1.19

231

1646

(3037467) Urinalysis macro (dipstick) panel - Urine

6278

24763

3.55

307.65

7.4

2.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1029

1823

4.41

307.65

2.5

1.9

8.58

10.93

ug/l

1.39

902

1617

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

553

447

9.33

307.65

5.5

4.1

4.11

1.88

ratio

0.51

(3017143) Hepatitis C virus Ab [Presence] in Serum

1777

4292

3.42

307.65

2.3

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2561

6022

3.82

307.65

2.5

1.6

1.38

1.42

mg/l

0.15

2049

4511

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1250

1485

6.80

307.65

7.7

3.3

128.01

78.31

ng/l

27.79

1137

1292

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1007

1220

6.49

307.65

9.3

3.6

23.80

24.25

mmol/l

3.47

984

1199

(3015377) Calcium [Moles/volume] in Serum or Plasma

3361

10827

2.92

307.65

5.0

4.2

2.33

2.36

mmol/l

19.43

3013

9741

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1266

528

19.69

307.65

1.6

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2087

5110

3.48

307.65

4.2

2.3

1.14

1.27

e6/l

0.44

1310

2584

(40760892) CBC W Ordered Manual Differential panel - Blood

5305

15051

4.58

307.65

13.0

5.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1627

2680

5.05

307.65

10.9

7.3

5.01

5.11

kpa

2.57

1542

2558

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

510

380

10.09

307.65

2.0

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

689

575

9.17

307.65

2.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2587

5675

4.14

307.65

1.8

1.3

19.70

20.23

nmol/l

0.85

2316

4855

(3019309) Folate [Moles/volume] in Red Blood Cells

2151

3977

4.73

307.65

1.9

1.6

1141.46

1134.71

nmol/l

0.11

1718

2910

(3013650) Neutrophils [#/volume] in Blood by Automated count

6013

20305

4.21

307.65

17.9

8.8

4.31

3.89

e9/l

25.02

5498

17357

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

435

307

10.57

307.65

2.3

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1447

3073

3.80

307.65

3.4

2.3

0.21

0.22

g/l

2.15

1341

2910

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1551

3036

4.18

307.65

1.3

1.1

10.90

1.45

u/ml

7.37

544

1272

(3000991) Gas panel - Venous blood

1408

2291

5.00

307.65

14.3

7.5

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2445

4117

5.41

307.65

4.5

1.9

11.73

14.25

umol/l

39.59

2332

3856

(3000850) Epithelial cells [#/volume] in Urine

2519

5903

3.82

307.65

4.5

2.1

5.27

6.02

e6/l

1.80

2343

5181

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5866

17644

4.79

307.65

11.6

6.9

10.61

12.41

umol/l

17.24

5653

16804

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

569

586

7.32

307.65

4.3

2.1

2.97

2.95

g/l

0.16

517

528

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3820

10161

3.88

307.65

5.1

2.3

44.09

56.13

ng/l

1.05

2826

5604

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1699

3964

3.53

307.65

5.6

2.9

8.09

10.34

umol/l

2.78

1481

3514

(3024561) Albumin [Mass/volume] in Serum or Plasma

4964

13280

4.62

307.65

11.2

4.8

34.00

35.83

g/l

69.84

4696

12339

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1417

3207

3.55

307.65

4.0

2.3

44.96

43.99

u/l

0.03

1230

2811

(3020779) Urea [Moles/volume] in Serum or Plasma

1742

2235

6.63

307.65

18.2

5.6

11.44

8.28

mmol/l

42.68

1688

2157

(3019060) Gas panel - Arterial blood

992

1283

6.07

307.65

6.9

4.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5225

14342

4.70

307.65

17.2

5.2

1.21

mmol/l

8.74

4602

12095

(3026008) Bacteria identified in Urine by Culture

3371

8361

3.96

307.65

4.4

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3999

9466

4.56

307.65

4.4

2.3

56.56

70.01

u/l

1.46

3788

8764

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

370

128

21.46

307.65

1.6

1.1

—

(3018418) pH of Serum or Plasma

3284

8088

3.95

307.65

10.0

3.5

7.40

0.16

630

1469

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2960

6544

4.29

307.65

4.2

2.4

2321.39

1058.98

ng/l

18.21

2614

5583

(3026250) Tacrolimus [Mass/volume] in Blood

348

31.84

307.65

41.5

29.8

7.38

7.41

ug/l

0.05

316

(3026782) Osmolality of Urine

2445

5879

3.68

307.65

5.0

2.3

516.50

560.71

mosm/kgh2o

17.13

2200

4969

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

618

643

7.28

307.65

2.0

1.4

117.09

104.36

u/ml

0.60

125

134

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4498

16059

2.96

307.65

4.7

2.3

185.45

114.29

ug/l

21.01

4240

15139

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2075

3638

4.97

307.65

3.5

2.2

30.02

30.14

0.32

2016

3546

(3015235) Bicarbonate [Moles/volume] in Capillary blood

491

400

9.20

307.65

4.8

3.1

24.00

24.63

mmol/l

1.52

478

387

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1638

3444

3.91

307.65

1.4

1.1

29.06

15.77

iu/ml

4.00

561

1063

(3022096) Basophils/100 leukocytes in Blood

5150

15041

4.28

307.65

12.1

4.6

0.64

0.68

5.30

4907

13940

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1000

565

14.06

307.65

12.8

4.3

3663.58

549.02

iu/ml

0.99

342

(3037522) Nuclear Ab [Titer] in Serum

1698

2799

5.09

307.65

1.5

1.2

495.05

431.00

titre

0.63

380

418

(3002030) Lymphocytes/100 leukocytes in Blood

5363

16508

4.16

307.65

12.4

4.5

26.49

29.02

42.12

5122

15465

(3025159) Blasts/100 leukocytes in Blood

1122

1849

4.80

307.65

6.7

3.6

0.30

0.71

0.69

564

536

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2263

3155

6.46

307.65

15.4

5.0

1.09

1.03

mmol/l

12.23

2160

2964

(3048689) Calprotectin [Mass/mass] in Stool

1844

4190

3.68

307.65

3.9

2.6

267.31

135.14

ug/g

15.43

1586

3367

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3967

10726

3.88

307.65

2.4

1.5

95.13

96.12

pmol/l

0.55

2359

5487

(3019198) Lymphocytes [#/volume] in Blood

5608

16977

4.48

307.65

11.5

4.5

1.84

1.95

e9/l

3.22

5173

14785

(3017181) Myelocytes/100 leukocytes in Blood

1334

2045

5.28

307.65

6.6

3.6

0.96

1.01

0.22

783

709

(3027945) Reticulocytes/100 erythrocytes in Blood

1849

2801

5.65

307.65

3.9

2.5

1.93

1.63

18.76

1685

2501

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

614

671

6.93

307.65

1.5

1.3

276.91

247.97

u/ml

1.17

408

453

(3028026) IgM [Mass/volume] in Serum or Plasma

1210

1416

6.87

307.65

2.1

1.9

1.30

1.40

g/l

0.52

1106

1292

(3024354) Oxygen [Partial pressure] in Venous blood

1272

1709

6.01

307.65

7.2

2.8

4.96

4.66

kpa

2.91

1221

1648

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4213

13132

3.38

307.65

3.2

1.9

75.04

76.21

nmol/l

1.62

3895

11970

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

513

406

9.50

307.65

2.8

1.6

—

(3021788) Differential panel - Synovial fluid

259

40.46

307.65

1.7

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1753

3073

4.80

307.65

2.4

1.5

—

(40758558) Short blood count panel - Blood

2930

8963

2.96

307.65

12.5

7.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

515

420

9.21

307.65

2.7

1.5

—

(3033658) Prothrombin time (PT) actual/Normal

2946

8808

3.04

307.65

8.0

3.5

90.81

91.86

1.30

2879

8636

(3003396) Base excess in Arterial blood by calculation

1637

2679

5.09

307.65

10.9

7.2

0.84

0.78

mmol/l

0.22

1338

2159

(3008152) Bicarbonate [Moles/volume] in Arterial blood

885

1241

5.53

307.65

10.8

6.4

24.22

24.54

mmol/l

1.14

840

1175

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7894

42907

3.20

307.65

37.3

7.9

27.25

26.84

mg/l

0.45

7113

29839

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

470

260

13.55

307.65

8.2

6.4

11.79

10.95

mg/l

2.13

401

246

(3019069) Monocytes/100 leukocytes in Blood

5300

15731

4.31

307.65

12.9

4.8

8.66

8.55

1.44

5056

14673

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

716

781

7.01

307.65

4.7

3.2

0.29

0.33

u/ml

2.21

399

400

(36304419) Bacteria [Presence] in Urine

3018

8447

3.31

307.65

5.5

2.4

—

(3018010) Neutrophils/100 leukocytes in Blood

5297

16181

4.15

307.65

11.7

4.4

58.38

56.18

26.96

5058

15153

(3002179) Metamyelocytes/100 leukocytes in Blood

1230

1867

5.28

307.65

6.3

3.6

0.78

0.71

0.35

698

630

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3664

11832

3.01

307.65

5.7

3.1

33.72

34.85

u/l

0.27

3510

11329

(3002032) Base excess in Venous blood by calculation

1641

2106

6.55

307.65

8.8

3.2

1.50

1.87

mmol/l

2.73

1396

1762

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

981

1301

5.91

307.65

2.2

1.4

—

(3002582) Erythrocytes [#/volume] in Urine

3394

9499

3.46

307.65

5.9

2.5

41.74

113.60

e6/l

3.66

2844

6810

(3026493) Urate [Moles/volume] in Serum or Plasma

3004

7085

4.01

307.65

4.8

2.1

2636.22

6079.85

umol/l

4.70

2710

6418

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

663

676

7.47

307.65

2.0

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2216

5376

3.56

307.65

5.2

2.7

390.02

963.58

ng/l

6.31

1736

3946

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

585

618

7.15

307.65

1.6

1.5

312.80

173.33

titre

0.58

(3013707) Erythrocyte sedimentation rate by Westergren method

6592

25011

4.11

307.65

6.6

2.3

16.61

10.16

mm/h

136.24

6243

22678

(3021440) Promyelocytes/100 leukocytes in Blood

1193

1940

4.90

307.65

6.8

3.7

0.11

0.12

0.09

649

613

(3013512) EKG study

2637

8568

2.68

307.65

5.1

2.8

—

(3013115) Eosinophils [#/volume] in Blood

5663

16946

4.60

307.65

12.1

4.8

0.18

0.19

e9/l

1.24

5185

14618

(3016502) Oxygen saturation in Arterial blood

1490

2341

5.23

307.65

11.4

7.8

95.26

96.30

5.98

1421

2260

(3009261) Glucose [Presence] in Urine by Test strip

4550

17166

2.76

307.65

5.6

2.4

0.00

estimate

-0.00

877

2900

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4536

16927

2.80

307.65

4.4

2.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1098

982

8.93

307.65

6.6

4.1

1.46

1.71

mmol/l

0.81

827

703

(3018095) Leukocytes [#/volume] in Urine

3767

11397

3.30

307.65

6.7

2.8

70.89

104.17

e6/l

1.53

2973

7408

(3006504) Eosinophils/100 leukocytes in Blood

5260

15637

4.27

307.65

12.3

4.6

2.62

2.90

13.82

5018

14559

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

925

828

8.76

307.65

2.8

1.8

2.51

2.46

ug/l

0.02

845

741

(3007164) IgA [Mass/volume] in Serum or Plasma

2380

6400

3.23

307.65

1.8

1.3

2.37

2.26

g/l

1.59

1603

4033

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

744

422

13.61

307.65

4.7

2.8

1461.95

935.03

u/ml

0.24

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3219

5826

5.53

307.65

2.9

1.6

203.29

198.02

u/l

0.12

3049

5435

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1001

1457

5.38

307.65

1.8

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

614

611

7.62

307.65

4.2

2.1

3.56

3.70

g/l

0.82

562

553

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

616

612

7.63

307.65

4.2

2.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1989

5080

3.29

307.65

4.7

2.4

2.63

2.42

e6/l

0.40

1217

2559

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2307

3749

5.53

307.65

4.6

1.8

2.20

2.35

g/l

22.32

2194

3473

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1869

2489

6.47

307.65

2.6

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

772

930

6.38

307.65

7.2

2.7

24.67

25.24

mmol/l

3.06

744

901

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1025

1957

4.08

306.55

4.0

2.4

254.86

200.72

ng/l

2.12

944

1796

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

426

320

9.92

305.79

1.9

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

399

273

10.86

303.73

1.9

1.3

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

951

1733

4.25

301.76

12.4

6.9

24.50

24.77

mmol/l

1.18

940

1723

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

515

517

7.47

299.32

1.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

547

601

6.85

294.76

1.5

1.3

264.83

275.22

ug/g

0.40

329

355

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

637

830

5.81

293.37

7.7

3.1

50.37

46.11

2.81

630

819

(42529406) Shigella sp [Presence] in Stool by Culture

653

874

5.67

292.85

1.5

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

651

869

5.68

292.73

1.5

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

651

869

5.68

292.73

1.5

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

363

226

11.90

291.97

1.7

1.3

601.41

430.92

mg/l

1.47

345

209

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6094

30155

2.31

291.41

4.4

3.0

14.77

14.50

pmol/l

12.78

5642

27390

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1214

2741

3.49

286.47

4.9

2.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

281

109

18.96

282.65

1.8

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

812

1372

4.54

282.09

12.7

9.3

23.95

24.28

mmol/l

1.79

782

1325

(3048929) Epstein Barr virus Ab [Presence] in Serum

760

1220

4.76

280.28

1.5

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7913

44564

2.91

276.90

38.8

8.8

139.23

139.85

mmol/l

83.95

7797

42771

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

274

105

19.17

276.89

1.8

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

619

839

5.58

273.79

7.3

3.9

1.98

1.20

mg/l

53.04

589

784

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2244

7369

2.55

273.17

1.4

1.2

1.83

2.34

u/ml

0.72

551

2007

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

561

691

6.11

272.40

2.2

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

495

532

6.96

271.57

4.0

2.3

0.94

1.29

g/l

0.64

429

461

(3037756) Immunofixation for Serum or Plasma

402

332

8.99

270.39

2.4

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7920

44829

2.87

268.93

39.5

8.9

3.97

3.94

mmol/l

19.19

7789

42898

(3028626) Oxygen [Partial pressure] in Capillary blood

472

486

7.26

268.39

5.7

4.5

8.38

8.65

kpa

1.69

462

473

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

382

296

9.57

268.38

2.2

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

822

1462

4.31

267.92

14.7

9.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

651

946

5.21

267.77

1.8

2.3

38.49

41.54

u/l

2.49

572

870

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

328

199

12.17

267.53

1.6

1.3

3.83

3.50

mmol/l

4.62

310

183

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

288

135

15.69

267.44

2.0

1.4

—

(3044941) Cell count panel - Synovial fluid

225

31.64

266.56

1.4

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

845

1543

4.20

266.42

13.9

8.9

1.34

1.29

0.73

834

1537

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1185

2769

3.36

264.36

1.7

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

429

404

7.90

261.90

5.0

3.5

1.53

1.83

0.63

396

356

(3042733) HLA Ab [Presence] in Serum

231

26.83

261.65

5.0

3.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1808

5465

2.70

258.01

3.6

3.7

2.46

2.45

mmol/l

2.25

1569

4809

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

421

403

7.77

253.70

1.8

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

338

237

10.53

253.15

2.8

1.8

—

(40768446) Kidney Pathology biopsy report

214

30.65

251.50

2.2

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

310

190

12.02

251.34

1.9

1.4

—

(3021901) Oxygen saturation in Capillary blood

365

292

9.25

250.84

4.1

2.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

267

122

16.06

250.73

2.9

1.9

201.91

121.78

ug/min

0.60

161

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

317

203

11.51

250.67

1.9

1.4

526.58

271.01

e6/l

0.56

265

153

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

316

204

11.42

248.70

1.8

1.4

11.37

9.03

e6/l

0.16

250

146

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

606

894

5.11

244.87

8.7

4.8

1.74

1.68

0.40

563

830

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7020

38195

2.31

242.76

5.5

3.3

1.89

2.51

mu/l

3.31

6569

34875

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3289

13381

2.17

240.93

6.0

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2329

8194

2.38

240.64

2.3

1.9

—

(3022145) Colonoscopy Study observation

1465

4097

2.85

240.48

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

351

282

9.20

240.45

2.2

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

351

282

9.20

240.45

2.2

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

480

577

6.21

238.04

1.3

1.1

0.87

0.61

u/ml

0.25

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

229

20.42

237.24

2.5

1.5

39233.36

3545.00

u/ml

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

316

222

10.49

236.30

2.9

1.8

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

590

880

5.05

235.43

9.0

4.8

0.91

0.90

0.21

549

816

(1616796) Gas panel - Central venous blood

407

411

7.35

234.86

6.6

2.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

672

1127

4.51

234.55

3.3

1.8

—

(3023419) Bacteria identified in Sputum by Culture

344

282

9.01

232.34

3.3

2.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

433

479

6.72

231.33

3.9

2.1

0.01

0.05

g/l

0.67

392

439

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

639

1040

4.64

231.00

4.0

2.3

3.51

3.53

g/l

0.12

609

996

(3011412) CD3 cells [#/volume] in Blood

319

237

9.92

230.19

3.2

2.3

1.34

1.14

e9/l

1.73

286

207

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

333

265

9.27

229.55

2.4

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

304

211

10.60

229.00

7.1

3.5

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

172

56.87

228.71

2.0

1.1

62.62

58.42

0.16

133

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

227

18.86

228.20

1.9

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

227

18.86

228.20

1.9

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1965

6572

2.44

225.02

2.2

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

398

412

7.16

224.95

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

443

519

6.35

224.81

7.3

3.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

407

433

6.98

224.81

2.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

475

600

5.91

224.63

2.2

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

430

491

6.51

223.32

3.7

2.1

36.61

38.33

g/l

4.15

377

434

(3019225) pH of Specimen

1094

2692

3.16

222.98

8.8

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

2323

8428

2.29

221.22

6.4

2.5

0.00

estimate

1.23

845

2755

(40761535) Cells panel - Urine sediment

870

1862

3.58

219.80

5.5

2.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

250

132

13.87

219.19

7.1

2.1

0.97

0.74

nmol/l

2.15

209

121

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

610

1020

4.50

213.28

2.6

1.6

—

(3047181) Lactate [Moles/volume] in Blood

514

739

5.20

213.07

9.3

5.4

1.27

1.31

mmol/l

0.31

452

649

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

478

644

5.54

211.96

1.8

2.2

12.35

10.29

mg/l

4.05

433

611

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

392

439

6.61

206.99

3.9

2.1

0.00

g/l

0.50

353

400

(3013139) Helicobacter pylori Ag [Presence] in Stool

951

2247

3.25

206.27

1.5

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1953

6754

2.35

205.71

5.7

2.5

1.02

kg/l

0.39

322

1060

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

387

435

6.59

203.66

3.9

2.2

0.00

g/l

-0.00

352

400

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5765

30036

1.99

202.82

5.4

2.3

64.56

40.28

u/l

37.15

5466

28356

(3006184) Hemoglobin [Mass/volume] in Capillary blood

407

491

6.15

200.83

3.0

1.9

122.66

131.62

g/l

6.70

301

364

(3003327) Ova and parasites identified in Stool by Light microscopy

630

1141

4.16

199.35

1.9

1.7

—

(3044889) 12 lead EKG panel

5379

27552

1.95

195.56

4.8

2.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

276

214

9.46

193.48

1.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6823

38138

2.07

190.67

7.2

2.8

40.44

36.22

mmol/mol

206.27

6417

35060

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

415

540

5.70

190.34

1.6

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

415

540

5.70

190.34

1.6

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

452

644

5.22

188.91

5.9

3.6

1.37

1.40

mmol/l

0.14

445

638

(3008757) Leukocyte morphology finding [Identifier] in Blood

297

267

8.17

187.43

5.5

3.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

260

194

9.82

186.92

3.0

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

260

194

9.82

186.92

3.0

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

260

194

9.82

186.92

3.0

1.6

—

(3024932) HLA-DR beta [Type]

201

15.59

186.61

1.1

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

37.78

186.55

5.8

6.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

248

173

10.49

186.08

3.4

2.5

0.21

0.22

e9/l

0.18

214

143

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

251

179

10.26

185.75

3.3

2.5

712.23

512.95

e6/l

2.77

211

148

(3029634) Reagin Ab [Titer] in Serum by VDRL

389

490

5.87

184.11

2.5

2.6

9.20

16.59

titre

—

(3024471) HLA-A [Type]

201

15.10

183.93

1.0

—

(3037121) Protein [Mass/volume] in Urine

552

962

4.29

183.05

4.8

3.7

0.38

0.19

g/l

6.43

332

514

(40767503) Oxygen content in Capillary blood by calculation

356

413

6.36

181.97

4.1

1.9

15.56

16.44

2.25

219

162

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

571

1051

4.07

176.57

3.5

2.3

90.19

88.83

0.53

550

1010

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

254

202

9.20

174.96

3.9

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

363

450

5.96

174.39

2.6

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

339

392

6.37

173.74

1.1

—

(3036489) Thrombin time

570

1070

3.99

171.71

3.3

2.0

22.00

21.58

0.78

519

937

(3020891) Body temperature

473

779

4.52

167.80

9.0

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

225

159

10.33

167.41

3.2

2.5

1.23

0.94

g/24h

0.61

143

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

180

15.59

167.23

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

595

1179

3.78

166.53

1.6

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

913

2405

2.90

163.54

4.3

2.2

54.88

72.00

ml/min/173m2

23.78

429

787

(3004716) Salmonella sp identified in Stool by Organism specific culture

817

2019

3.07

163.37

1.6

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

691

1542

3.38

162.65

4.5

2.1

0.24

0.33

e6/l

0.91

674

1495

(3017354) Segmented neutrophils/100 leukocytes in Blood

264

246

7.86

162.03

5.0

3.8

57.70

55.16

0.71

240

200

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

347

447

5.72

160.53

1.3

1.1

19.67

3.31

u/ml

0.88

(3007566) Smooth muscle Ab [Titer] in Serum

487

852

4.25

160.43

1.3

1.4

101.89

147.12

titre

0.42

(3003181) Sodium [Moles/volume] in Urine

299

330

6.65

159.66

1.9

1.4

57.81

62.66

mmol/l

0.74

248

238

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

850

2179

2.97

159.55

10.0

3.1

1.22

1.23

mmol/l

3.17

790

1859

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

323

391

6.08

158.61

1.3

1.1

5.29

7.21

u/ml

0.21

(21494815) CD4 cells/100 lymphocytes in Specimen

272

273

7.30

157.37

2.8

2.1

34.22

36.35

0.98

263

268

(3034770) Mitochondria Ab [Titer] in Serum

476

834

4.24

156.46

1.3

832.86

895.86

titre

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

227

182

9.11

155.43

2.4

1.9

—

(3042631) Mycobacterium sp identified in Specimen

288

314

6.73

155.42

4.1

2.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

159

17.49

155.36

1.5

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

247

224

8.06

154.74

1.5

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

317

388

6.01

154.03

1.3

1.1

3.55

2.69

u/ml

0.41

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7209

42294

2.00

153.90

28.7

8.0

79.03

84.59

ml/min/173m2

60.34

6221

33124

(3017732) Neutrophils [#/volume] in Blood

823

2114

2.95

153.75

3.8

2.6

5.01

4.21

e9/l

0.74

659

1781

(3018572) Chloride [Moles/volume] in Blood

363

517

5.18

151.48

10.9

6.7

105.11

105.03

mmol/l

0.08

326

460

(3039000) Anion gap in Blood

363

517

5.18

151.48

10.9

6.7

11.42

11.14

mmol/l

0.63

326

460

(3014148) Varicella zoster virus Ab [Titer] in Serum

318

400

5.84

150.51

1.2

—

(3010421) pH of Blood

378

569

4.90

148.52

8.2

2.9

7.42

0.34

348

529

(3024980) IgG subclass 4 [Mass/volume] in Serum

319

409

5.73

148.19

1.6

1.5

0.69

0.85

g/l

0.84

225

313

(3012501) Base excess in Blood by calculation

350

493

5.23

147.75

8.0

3.0

2.44

2.56

mmol/l

0.24

242

313

(3013290) Carbon dioxide [Partial pressure] in Blood

350

493

5.23

147.75

8.0

3.0

4.89

4.91

kpa

0.17

339

483

(3027315) Oxygen [Partial pressure] in Blood

351

496

5.21

147.67

8.0

3.0

8.79

8.78

kpa

0.01

340

486

(3044927) Protein electrophoresis panel - Urine

177

103

12.49

147.39

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

270

294

6.73

145.83

1.3

1.1

1.37

1.16

u/ml

0.35

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

687

1637

3.16

145.41

2.4

2.2

22.25

24.01

au/ml

0.14

222

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

171

12.94

145.13

1.2

1.1

3243.73

22.81

iu/ml

0.50

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

636

1447

3.30

144.91

1.3

1.2

40.12

47.25

au/ml

0.34

131

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

174

102

12.40

144.32

1.2

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

452

820

4.09

141.99

4.9

2.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

494

959

3.83

141.85

4.0

2.1

207.85

185.49

4.90

468

912

(3041096) Erythrocytes [Presence] in Urine by Automated

2351

9949

1.92

139.64

5.5

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

759

1965

2.92

139.43

1.5

1.2

246.10

294.63

u/ml

0.59

683

1822

(3010144) Erythrocytes [#/volume] in Synovial fluid

125

24.44

137.89

1.5

1.0

208181.83

53005.08

e6/l

0.87

(3037692) Legionella sp identified in Specimen by Organism specific culture

152

14.70

137.56

1.6

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

168

102

11.96

136.67

3.8

2.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

115

30.78

135.43

2.0

1.1

31.42

29.02

0.13

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

651

1569

3.11

135.00

3.0

2.8

4.32

4.48

pmol/l

3.18

577

1391

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

100

60.15

133.97

12.2

7.6

5.04

4.51

mmol/l

0.63

100

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

132

19.11

133.71

1.4

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

190

148

9.34

132.64

3.2

2.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

179

131

9.93

130.19

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

283

369

5.62

129.22

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

173

122

10.30

128.82

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

208

195

7.77

126.98

2.8

2.7

34.99

36.56

0.36

107

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

189

159

8.64

125.07

2.3

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

142

13.72

124.31

1.3

1.1

2.17

1.92

mmol/l

0.99

132

(40768804) Tissue Pathology biopsy report

3604

17868

1.72

124.16

2.4

2.0

—

(3016018) Differential panel - Cerebral spinal fluid

168

124

9.84

121.51

1.8

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

222

238

6.80

121.46

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

315

484

4.78

120.79

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

288

411

5.13

119.78

8.1

2.4

—

(4062490) Immunoglobulin typing, IgG

211

218

7.05

119.11

1.6

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

333

549

4.46

117.63

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

172

139

8.98

117.07

3.7

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

171

139

8.93

115.92

3.7

1.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

207

217

6.94

115.43

1.6

1.2

0.38

0.41

g/l

0.45

144

148

(3040151) Glucose [Moles/volume] in Capillary blood

201

204

7.17

115.15

6.4

2.9

7.37

6.07

mmol/l

5.68

168

171

(3028192) IgG subclass 2 [Mass/volume] in Serum

207

218

6.91

114.98

1.6

1.2

2.69

3.21

g/l

2.38

143

151

(3000012) Reticulocyte production index

247

317

5.69

114.52

2.9

2.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

124

9.48

114.40

2.1

1.4

—

(4200892) Spirometry reversibility

718

2005

2.69

114.10

1.6

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

206

219

6.85

113.51

1.6

1.2

6.85

6.80

g/l

0.04

142

149

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

19.86

113.11

1.2

1.0

—

(3045414) Leukocytes [Presence] in Urine

508

1175

3.21

112.25

2.6

1.6

—

(40761511) CBC panel - Blood by Automated count

7815

48700

1.96

111.67

30.5

7.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

100

24.88

110.96

2.1

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

256

353

5.30

110.37

1.4

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

18.47

110.03

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

173

154

8.16

109.84

1.4

1.2

—

(3008898) HLA-B27 [Presence]

327

566

4.24

108.79

1.1

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

23.81

108.35

1.7

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

107

18.84

107.86

3.4

2.5

—

(3017704) Immunofixation for Urine

127

12.76

107.19

2.2

1.9

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

198

215

6.70

107.13

1.2

186.15

276.29

titre

0.50

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

185

189

7.11

105.40

2.6

1.6

5.11

3.12

mg/l

3.52

171

181

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

147

110

9.68

105.37

4.0

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

177

173

7.43

104.54

1.3

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

225

289

5.67

104.22

3.2

2.8

0.86

0.79

nmol/l

1.02

160

215

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

124

12.63

104.11

1.1

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7102

43237

1.76

104.09

5.4

3.0

6.03

5.49

mmol/l

165.17

6575

39813

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

119

13.65

104.03

4.5

3.5

—

(3002385) Erythrocyte distribution width [Ratio]

6677

39963

1.70

104.03

39.7

10.2

15.41

14.51

10.64

6611

38904

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7963

50237

1.98

103.83

21.2

6.5

26.91

25.83

u/l

2.51

7802

48197

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

100

20.04

103.19

1.4

1.6

—

(36660697) Celiac disease serology panel - Serum

831

2618

2.39

102.79

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

162

7.62

102.44

1.5

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

162

7.62

102.44

1.5

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

144

110

9.48

101.82

4.0

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

144

110

9.48

101.82

4.0

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

108

9.52

100.70

2.2

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

141

107

9.54

100.14

2.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

110

14.71

99.75

2.9

1.7

719.43

726.32

0.04

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

378

779

3.57

99.43

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

141

110

9.28

98.31

2.2

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

19.03

96.16

2.8

1.8

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

245

369

4.84

96.01

1.3

1.1

40.13

21.92

u/ml

0.89

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

566

1527

2.75

95.61

2.5

2.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

313

580

3.95

95.35

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

123

10.84

94.77

1.4

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2123

9645

1.74

94.48

1.9

1.5

1.47

1.26

mmol/l

17.12

1897

8310

(3008037) Lactate [Moles/volume] in Venous blood

269

452

4.35

92.78

6.0

2.3

1.45

1.43

mmol/l

0.07

263

440

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

100

15.35

92.52

1.1

1.0

418.55

216.23

mg/l

1.42

(3045142) Bone marrow Pathology biopsy report

233

350

4.85

91.58

1.6

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

101

14.57

91.22

1.2

1.0

68.43

28.51

mg/l

1.04

(3009466) Valproate [Moles/volume] in Serum or Plasma

207

280

5.38

91.01

5.9

6.4

355.40

405.57

umol/l

4.27

189

241

(3003434) Protein [Mass/volume] in Pleural fluid

247

400

4.50

89.04

1.6

1.3

29.60

35.64

g/l

7.55

219

360

(3038515) Glucose [Moles/volume] in Venous blood

255

425

4.38

88.82

6.1

2.4

7.24

6.42

mmol/l

6.42

250

415

(3035947) Staphylolysin Ab [Units/volume] in Serum

117

10.56

88.78

1.1

3.70

3.13

iu/ml

—

(4146454) Self-monitoring of blood glucose

15.57

88.47

2.5

1.5

—

(3008295) Osmolality of Serum or Plasma

172

200

6.24

87.56

1.4

1.6

280.61

277.84

mosm/kgh2o

0.56

134

169

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

166

189

6.37

86.14

3.3

3.1

95.61

92.61

0.34

160

180

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

135

120

8.14

85.81

1.4

1.1

—

(21494434) Karyotype in Bone marrow

187

243

5.59

85.62

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

217

325

4.86

85.57

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

16.03

83.99

1.8

1.0

6.03

5.05

u/l

0.55

(21494814) CD8 cells/100 lymphocytes in Specimen

113

10.20

83.92

2.6

1.6

—

(3000330) Specific gravity of Urine by Test strip

511

1398

2.70

83.90

5.5

2.6

—

(4035726) Immunohistochemistry procedure

1073

4080

1.99

82.49

1.7

1.4

—

(3051651) Icteric interference index of Serum or Plasma

166

199

6.05

82.16

6.1

3.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

190

263

5.25

81.57

1.3

1.2

62.51

76.19

u/l

0.57

173

238

(3016750) Collection duration of Urine

13.68

81.48

3.3

1.8

477.89

489.14

min

0.26

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

168

206

5.91

81.40

1.1

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

123

104

8.55

81.09

4.7

2.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

168

207

5.88

81.02

1.1

1.0

—

(3011648) Oxygen content in Venous blood

173

220

5.70

80.93

6.1

3.5

10.43

11.03

0.95

173

220

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

14.57

80.42

1.1

1.0

—

(3022621) pH of Urine by Test strip

646

2026

2.37

80.10

3.6

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

157

183

6.21

79.76

1.4

1.1

50.69

18.52

u/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

230

387

4.33

79.18

1.3

1.2

63.21

39.38

u/l

0.85

204

335

(3006922) Hepatitis E virus Ab [Presence] in Serum

174

228

5.53

79.02

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

195

285

4.97

78.99

1.4

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

954

3536

2.03

78.50

12.9

4.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

28.34

77.18

1.2

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1071

4168

1.94

76.74

4.7

3.3

32.30

32.25

0.04

820

2709

(3024891) Influenza virus A+B Ag [Presence] in Specimen

394

981

2.95

76.68

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

238

424

4.09

76.28

2.1

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

14.58

75.02

1.6

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

185

274

4.90

73.87

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

445

1217

2.69

72.98

1.1

66.38

3.93

u/ml

—

(3023199) Leukocytes [#/volume] in Pleural fluid

216

370

4.24

72.74

1.6

1.4

3472.36

3615.66

e6/l

0.02

162

253

(3022493) Free Hemoglobin [Mass/volume] in Plasma

113

8.24

72.61

7.0

5.9

59.20

73.64

mg/l

0.91

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

134

146

6.64

72.31

1.4

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

134

146

6.64

72.31

1.4

2.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

163

219

5.39

72.18

4.0

2.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

225

401

4.08

72.08

2.3

2.2

1821.18

2823.23

titre

0.24

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

18.24

70.72

2.5

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

215

376

4.16

70.55

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

14.98

70.50

1.7

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

117

112

7.54

70.28

2.8

3.5

97.81

234.56

au/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1108

4486

1.87

70.12

3.7

5.0

22.61

42.98

ug/l

0.95

909

3600

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

21.57

69.92

1.1

1.0

1.06

1.05

u/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

12.10

69.06

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

112

104

7.77

68.89

1.4

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

112

104

7.77

68.89

1.4

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

112

104

7.77

68.89

1.4

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

104

7.70

67.81

1.4

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

111

104

7.70

67.81

1.4

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

104

7.70

67.81

1.4

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

199

338

4.27

67.73

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

206

360

4.16

67.67

1.5

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

191

317

4.37

66.87

5.8

2.7

—

(3006653) Thiamine [Moles/volume] in Blood

11.49

66.31

1.3

1.6

143.59

132.42

nmol/l

0.59

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

206

368

4.07

65.80

1.4

1.2

4.75

4.45

u/ml

0.11

168

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

123

136

6.53

65.54

3.5

4.1

7.72

9.00

mg/l

0.76

102

112

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

208

376

4.02

65.43

1.6

1.1

3.27

2.08

iu/l

1.60

(3019977) pH of Arterial blood

102

8.17

65.21

4.0

1.7

7.39

7.42

1.80

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

169

259

4.73

64.97

1.4

1.2

348.95

647.12

u/l

1.40

157

251

(3049717) Cytology report of Urine Cyto stain

417

1171

2.62

64.90

2.8

2.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5357

31995

1.47

64.77

3.6

2.9

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

226

438

3.75

64.77

1.1

1.62

1.50

g/l

3.07

201

407

(3000060) B lymphocytes [#/volume] in Blood

8.51

64.56

2.3

1.9

2771.00

731.16

e6/l

0.37

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2561

13217

1.53

63.97

4.6

2.56

3.48

ug/l

2.13

2311

12103

(21494755) Public health laboratory ask at order entry panel

485

7239

0.45

63.78

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

173

275

4.56

63.77

2.7

1.7

32.46

36.19

mg/l

0.25

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

335

853

2.87

62.61

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

11.07

62.57

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

211

400

3.83

62.33

1.4

1.2

2.85

2.16

u/ml

0.58

140

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

22.75

61.46

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

448

1338

2.46

61.46

1.8

1.7

—

(3014271) Vancomycin [Susceptibility]

9.91

61.40

3.4

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1175

5035

1.76

61.27

2.1

1.5

1.55

1.31

22.91

1029

4576

(3024263) Appearance of Synovial fluid

13.09

60.90

2.0

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

24.69

60.86

1.1

—

(3016038) Potassium [Moles/volume] in Urine

116

131

6.39

60.68

1.7

1.3

29.66

40.49

mmol/l

3.45

105

116

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

8.62

60.55

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

14.83

60.17

1.0

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

107

112

6.89

59.79

1.1

1541.68

1369.31

miu/ml

0.65

107

112

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

23.23

59.71

1.2

1.1

—

(3012441) Differential panel - Pleural fluid

183

323

4.11

59.38

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

10.34

59.30

2.5

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

9.13

58.88

2.2

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

118

142

6.00

58.25

1.3

111.50

101.01

u/l

0.29

103

129

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

23.78

57.96

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

16.23

57.92

1.1

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

141

205

4.97

57.50

1.4

1.2

18.50

13.06

u/l

1.63

126

196

(3028308) Erythrocytes [#/volume] in Pleural fluid

186

341

3.95

57.47

1.5

1.4

40734.54

35020.61

e6/l

0.14

114

199

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

114

136

6.05

56.74

1.3

32.84

21.90

u/l

1.06

101

118

(3020961) Endomysium IgA Ab [Titer] in Serum

513

1687

2.24

56.68

1.1

139.00

223.91

titre

—

(40761536) Microorganisms panel - Urine sediment

751

2864

1.95

56.29

7.4

2.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

8.99

54.86

2.3

1.5

118.10

144.18

umol/l

0.26

(40757494) Bilirubin.total [Moles/volume] in Blood

7.72

54.60

3.5

2.0

14.83

56.03

umol/l

—

(3017569) Oxygen content in Arterial blood

8.55

54.29

3.3

1.9

—

(3000492) Spirometry study

921

3828

1.80

52.77

1.7

1.3

—

(3048879) Bone marrow aspiration report

9.30

52.63

3.1

2.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

16.86

52.10

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

278

709

2.86

51.80

6.3

2.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

12.37

51.65

1.1

1.0

412.21

85.50

ng/l

—

(3047189) Immunofixation for 24 hour Urine

7.46

51.37

2.7

2.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

165

302

3.95

51.12

1.5

1.3

6.58

5.34

mmol/l

4.31

151

277

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

13.24

50.93

3.5

2.3

32.94

11.08

mg/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

21.53

50.79

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6907

44181

1.47

50.55

4.7

2.9

1.39

1.18

mmol/l

68.51

6418

41051

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

9.08

49.74

1.5

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

231

544

3.08

49.37

1.5

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

13.20

49.13

1.3

1.2

1411.98

79.52

ng/l

0.50

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

6.28

49.03

5.9

3.8

—

(3020393) Adenovirus Ag [Presence] in Stool

11.53

48.90

1.7

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

274

720

2.77

48.36

3.4

2.0

—

(40768443) Skin Pathology biopsy report

446

1478

2.21

48.29

1.3

1.2

—

(40768806) Pleura Pathology biopsy report

171

336

3.68

48.13

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

113

159

5.13

47.77

1.6

1.2

0.96

1.60

promille

3.32

127

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

159

299

3.85

47.54

1.4

1.2

0.35

0.14

nmol/l

0.64

(21491868) Cryoglobulin [Mass/volume] in Serum

8.33

47.47

1.3

1.1

0.08

0.17

g/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

333

978

2.48

47.25

1.4

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

159

304

3.78

46.49

1.4

1.2

0.58

0.62

nmol/l

0.57

151

292

(3011985) Renin [Units/volume] in Plasma

165

325

3.67

46.30

1.7

1.6

93.63

86.88

mu/l

0.06

143

293

(3045788) Cell count panel - Pleural fluid

159

306

3.76

46.08

1.6

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7244

47027

1.47

46.00

5.5

3.4

2.65

3.01

mmol/l

202.58

6759

43720

(3017315) Amylase [Enzymatic activity/volume] in Urine

120

5.76

45.76

1.2

176.81

272.36

u/l

1.57

114

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

111

5.97

45.36

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

120

188

4.60

45.07

1.2

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

142

257

3.99

44.68

2.4

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

8.43

44.61

2.1

2.3

37.93

86.29

u/l

0.55

(3001964) Herpes simplex virus Ag [Presence] in Specimen

6.77

44.19

2.2

1.2

—

(40757373) Influenza virus identified in Isolate

9.02

44.03

2.0

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

7.39

43.95

2.6

2.5

8.30

10.18

mg/l

1.40

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

333

1015

2.39

43.65

1.1

12.80

6.79

u/ml

0.36

199

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

106

153

4.99

43.64

1.8

1.5

6.06

5.90

u/l

0.03

125

(3010838) Calcium [Moles/time] in 24 hour Urine

195

448

3.15

43.42

1.7

1.9

4.57

5.95

mmol/24h

5.11

173

402

(3044242) Glucose [Moles/volume] in Arterial blood

6.92

43.35

3.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

144

271

3.84

43.04

1.4

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1595

8011

1.51

42.57

1.7

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

13.78

42.27

1.1

1.0

—

(3004451) EKG impression Narrative

6.75

41.88

1.4

1.2

—

(3002256) Pathology report gross observation

1216

5770

1.58

41.85

1.4

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

180

405

3.22

41.46

1.2

1.1

118.65

113.06

1.15

170

361

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

10.87

41.08

3.8

3.2

0.85

0.97

mg/l

0.19

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7124

46393

1.43

40.95

5.1

3.2

4.55

4.95

mmol/l

182.73

6672

43417

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

137

260

3.80

40.51

1.4

1.2

—

nmol/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7072

46085

1.41

39.44

5.0

3.2

1.41

1.53

mmol/l

94.85

6596

43035

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

119

207

4.15

39.44

1.1

1.0

290.83

291.37

mg/l

0.02

106

192

(40768441) Liver Pathology biopsy report

144

289

3.60

39.40

2.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

104

162

4.62

39.36

7.4

10.0

44.52

9979.83

u/ml

0.50

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

7.53

39.23

1.0

1.1

0.42

0.13

nmol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

9.69

39.00

1.1

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

145

295

3.55

38.91

1.2

1.1

93.29

94.49

0.18

138

275

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

131

5.06

38.47

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

508

6397

0.54

38.32

1.7

1.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

15.47

38.11

1.2

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

12.41

37.58

2.1

1.1

125.07

7.40

ug/min

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

19.85

36.98

2.2

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

120

5.16

36.75

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

142

297

3.45

36.62

1.4

434.00

390.82

pmol/l

0.18

123

263

(3006576) Bicarbonate [Moles/volume] in Blood

5.86

36.45

6.5

7.5

24.40

25.39

mmol/l

0.92

(3016244) Insulin [Units/volume] in Serum or Plasma

102

169

4.35

35.92

3.3

3.8

24.64

25.85

mu/l

0.07

157

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

6.42

35.42

12.9

7.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

6.00

35.31

1.6

1.3

60.69

60.51

0.01

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

12.55

35.27

2.5

4.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

432

1601

1.97

34.86

3.5

4.2

1188.70

1866.82

u/ml

0.27

368

1393

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

176

435

2.93

34.74

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

17.92

34.58

2.9

5.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

17.92

34.58

1.1

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

8.27

34.36

1.4

1.2

24.41

21.78

0.18

(3035880) pH of Pleural fluid

155

4.41

34.10

1.5

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

138

4.64

33.91

2.6

1.5

5107.26

1370.14

e6/l

0.44

(3009214) Lutropin [Units/volume] in Serum or Plasma

326

1099

2.16

33.82

1.5

1.4

10.90

10.39

u/l

0.25

274

886

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

250

3.58

33.76

3.1

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

7.92

33.30

8.1

21.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

7.06

33.27

1.2

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

147

4.45

33.06

1.5

1.4

19.94

23.35

u/ml

0.23

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

18.19

32.78

2.8

5.0

—

(3003694) ABO and Rh group [Type] in Blood

2348

13187

1.36

32.73

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

8118

54729

1.50

32.49

49.3

11.5

38.71

41.55

22.58

7600

51402

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.61

32.29

4.2

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

7.61

32.29

4.2

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

121

248

3.52

32.19

1.2

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

130

4.65

32.09

2.1

1.4

172.08

134.60

2.41

124

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

12.38

31.69

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

139

4.45

31.25

3.6

1.7

172.47

24.00

mg/l

1.94

(3038071) Oxygen [Partial pressure] in Mixed venous blood

6.24

30.99

13.5

6.4

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

5.88

30.76

1.4

1.1

12.22

12.76

g/l

0.13

(3007461) Platelets [#/volume] in Blood

8123

54872

1.48

30.73

48.7

11.5

252.62

251.93

e9/l

0.34

7997

52648

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

577

2444

1.73

30.49

1.2

124.72

155.04

iu/ml

0.91

187

959

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

17.08

30.02

1.4

1.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

5.60

29.87

1.3

1.2

111.53

104.68

0.42

(3035941) MCH [Entitic mass]

8126

54959

1.47

29.66

48.4

11.4

30.24

30.21

0.72

8044

53837

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

138

325

3.06

29.63

1.5

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

122

4.60

29.46

2.4

1.4

13613.96

5835.25

e6/l

0.45

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.35

29.39

4.9

1.7

—

(3010813) Leukocytes [#/volume] in Blood

8127

54991

1.47

29.26

48.7

11.5

7.12

6.39

e9/l

63.91

7985

52571

(3024731) MCV [Entitic volume]

8126

54987

1.47

29.19

48.5

11.4

91.27

90.40

48.64

8045

53861

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

13.91

29.18

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

8126

54991

1.47

29.13

48.6

11.4

4.32

4.57

e12/l

273.40

7985

52626

(3000963) Hemoglobin [Mass/volume] in Blood

8129

55040

1.47

28.72

48.9

11.5

129.50

137.51

g/l

307.65

8050

53909

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.53

28.65

1.7

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

692

3129

1.63

28.57

2.3

1.9

12.42

13.45

nmol/l

2.38

617

2881

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

5.54

28.19

1.2

84.81

91.59

0.44

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

107

222

3.47

28.02

1.5

1.4

14.78

11.49

umol/l

3.22

102

209

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

7.17

27.95

1.7

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

11.40

27.90

1.2

1.3

0.46

0.56

ug/l

0.25

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.89

27.61

2.6

3.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

12.44

27.59

1.2

1.3

1.13

1.53

ml/s/173m2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

13.88

27.37

1.8

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

226

721

2.27

26.82

1.5

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

6.22

26.81

1.5

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

198

3.56

26.69

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

237

774

2.22

26.62

3.4

4.2

627.63

1240.44

u/ml

0.52

209

706

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

341

4350

0.54

26.39

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1933

10838

1.35

26.29

4.0

3.8

22.11

21.08

1.78

855

5240

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

491

2075

1.73

26.12

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

5.19

25.96

1.3

1.1

82.96

94.32

1.17

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

209

3.44

25.93

1.4

1.2

2.56

2.60

u/ml

0.01

120

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

4.81

25.93

1.1

4.27

12.71

u/ml

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

5.64

25.87

1.7

1.4

3.25

2.92

0.08

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

164

460

2.57

25.69

1.9

2.1

18.90

25.69

ug/l

1.35

158

447

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

138

4.06

25.43

1.1

103.89

78.36

u/l

1.08

126

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

6.48

25.16

1.0

37.41

28.32

ng/l

1.02

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

6.48

25.16

1.0

277.93

262.29

ng/l

0.13

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

174

509

2.47

25.03

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

5.14

24.86

1.7

1.1

23.48

27.69

g/l

0.76

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

6.36

24.74

1.0

757.00

877.54

ng/l

0.68

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

8.25

24.65

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.25

24.65

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

9.85

24.12

1.4

1.0

1085.46

44.53

u/l

0.48

(3047007) Chlamydophila sp Ab [Presence] in Serum

175

523

2.42

24.07

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

113

4.32

23.98

2.3

1.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

11.31

23.80

1.9

1.6

2.36

6.31

mg/l

1.00

(3006270) Folate [Moles/volume] in Blood

211

3.31

23.72

1.2

1.1

334.70

393.82

nmol/l

1.85

198

(1761868) Lipid panel - Serum or Plasma

2219

19220

0.77

23.70

3.1

2.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.54

23.63

1.2

1.1

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

174

3.55

23.42

2.7

2.9

38857.86

42935.06

ug/l

1.11

174

(3028707) Methadone [Presence] in Urine by Screen method

185

579

2.31

23.00

3.0

2.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

151

430

2.53

22.99

3.0

3.6

10.41

5.16

nmol/l

1.10

141

420

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

141

388

2.62

22.98

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

147

3.76

22.75

1.4

1.6

—

(40758292) HTLV I+II Ab panel - Serum

5.03

22.66

1.6

1.4

—

(4212803) Bone marrow aspirate examination

10.93

22.56

1.2

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

105

249

3.03

22.39

1.9

1.7

2.76

1.43

u/field

1.12

107

(1002224) Polysomnography panel

298

1133

1.91

22.36

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

8.40

22.34

1.3

1.1

158.88

98.80

nmol/l

0.93

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

12.08

22.21

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

150

3.69

22.14

1.2

1.1

1.06

1.05

ratio

0.19

(3002079) Sodium [Moles/time] in 24 hour Urine

109

4.21

21.93

1.2

148.17

178.20

mmol/24h

1.52

109

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.12

21.41

2.8

2.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

2.03

3.45

mg/l

0.29

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

1.24

7.70

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

5.45

4.23

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

3.71

1.35

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

2.62

2.33

mg/l

0.06

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

2.73

0.72

mg/l

0.71

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

5.02

2.64

mg/l

0.60

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

10.55

21.34

1.9

1.6

4.27

3.18

mg/l

0.17

(3034426) Prothrombin time (PT)

4.81

21.22

1.3

1.1

—

(3011436) Histone Ab [Units/volume] in Serum

9.34

21.20

1.1

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

5.50

21.17

1.5

1.1

90.32

79.35

0.61

(3000919) Neutrophils/100 leukocytes in Pleural fluid

5.27

20.72

1.8

1.4

26.52

21.81

0.41

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.47

20.61

2.1

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

38.66

19.57

3.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.78

19.51

1.7

1.4

17.18

16.04

0.06

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.68

19.08

1.3

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

6.16

19.00

1.2

1.1

3.29

7.08

pmol/l

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

5.22

18.83

1.3

1.2

86.67

67.00

0.98

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

183

3.18

18.76

1.9

1.5

2.37

2.77

u/field

0.22

128

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.96

18.67

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.68

18.29

1.3

1.2

86.91

352.86

ug/l

0.87

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

175

592

2.13

18.16

1.1

28.01

11.73

au/ml

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

4.24

18.02

3.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

816

4210

1.42

17.91

1.7

1.8

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

22.28

17.91

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

5.76

17.87

2.4

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

24.17

17.67

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

18.88

17.66

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.44

17.37

1.3

1.1

1.27

2.15

mmol/l

2.74

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

6.55

17.34

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

199

720

2.00

17.31

1.4

1.2

—

(40765096) Chromosome analysis panel by Banding

4.11

17.03

1.4

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

18.23

16.89

1.1

—

(3044007) Cell count panel - Peritoneal fluid

116

3.65

16.84

2.7

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

4.32

16.70

2.0

1.5

5.11

5.20

nmol/l

0.01

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

6.92

16.47

4.6

4.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

6.92

16.47

1.2

1.4

6.08

262507.52

nmol/l

0.48

(3035320) C reactive protein [Mass/volume] in Body fluid

207

2.88

16.36

3.2

2.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

32.92

16.23

4.3

4.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

330

1430

1.67

16.07

1.7

1.6

368.71

301.51

mu/l

1.30

304

1293

(3008402) Methanol [Moles/volume] in Serum or Plasma

8.59

16.03

1.1

—

mmol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.26

15.93

1.2

1.3

336.59

338.90

pmol/l

0.01

(3001686) Cold agglutinin [Titer] in Serum or Plasma

5.26

15.93

1.1

1.2

132.00

501.25

titre

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

6.68

15.45

1.6

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

4.34

15.39

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

265

1096

1.75

15.29

1.8

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

14.87

15.23

2.0

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

226

2779

0.57

15.23

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.30

14.87

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

317

2.40

14.74

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

176

2.94

14.73

1.1

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

249

1025

1.75

14.62

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.44

14.45

1.2

—

(3036180) Methadone [Presence] in Urine

141

3.15

14.31

1.5

1.7

—

(40768795) Lymph node Pathology biopsy report

137

464

2.12

14.27

1.4

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

336

1517

1.60

13.97

2.5

2.2

6807.36

6561.89

u/l

0.04

105

657

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

111

348

2.29

13.93

1.8

1.7

—

(46236302) HLA-C [Type] by High resolution typing

7.87

13.81

1.0

1.1

—

(40763590) HLA-DQ beta [Type]

7.87

13.81

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

13.77

13.75

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

13.77

13.75

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

13.77

13.75

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

13.77

13.75

1.1

—

(3022689) Creatine [Moles/volume] in Urine

5.61

13.70

2.3

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

172

2.88

13.68

1.8

1.7

9.56

8.03

ug/l

0.24

156

(3019832) Treponema pallidum Ab [Presence] in Serum

902

4942

1.34

13.59

1.9

1.7

—

(3014891) Appearance of Pleural fluid

5.46

13.35

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

154

2.93

12.94

3.3

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

329

1508

1.58

12.87

1.2

212.84

227.68

miu/ml

0.25

108

744

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

5.42

12.79

1.3

1.1

22.26

16.83

u/l

0.51

(40760409) HLA-A [Type] by High resolution

7.51

12.73

1.0

1.1

—

(40760410) HLA-B [Type] by High resolution

7.51

12.73

1.0

1.1

—

(3013862) HLA-DP [Type]

7.51

12.73

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

20.44

12.65

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

12.27

12.64

2.2

1.6

49.42

45.07

umol/l

0.17

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

4.43

12.51

6.0

7.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

158

2.86

12.40

1.1

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

5.64

12.35

1.0

1.2

27.25

20.29

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

5.64

12.35

1.0

1.2

49.77

36.12

u/ml

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

6.13

12.32

2.9

2.0

59.46

55.10

0.16

(3033923) Metanephrine [Moles/time] in 24 hour Urine

4.88

12.32

1.0

0.57

0.74

umol/24h

0.93

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

12.66

12.30

1.8

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

6.33

12.14

2.6

2.2

15.99

13.58

umol/l

0.41

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

5.47

12.01

1.1

1.2

42.95

68.79

mg/l

1.11

(3050794) Legionella sp Ab [Presence] in Serum

6.56

11.97

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

199

816

1.76

11.92

4.5

2.3

34.54

28.48

mg/l

1.14

142

510

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

167

650

1.85

11.86

1.1

2.95

2.90

u/ml

0.02

380

(3003338) MCHC [Mass/volume]

6318

42725

1.18

11.13

41.7

10.1

330.91

333.21

g/l

66.18

6260

42293

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.83

10.99

1.5

1.0

0.47

0.93

mmol/l

0.46

(37021550) Renin [Units/volume] in Plasma --upright

4.51

10.94

1.2

1.6

335.27

65.23

mu/l

0.48

(3002621) Streptococcal DNAse B [Units/volume] in Serum

9.68

10.93

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

11.56

10.87

1.0

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

168

675

1.79

10.82

1.9

1.7

197.94

217.78

pmol/l

1.69

161

645

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.55

10.68

1.4

1.6

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

11.92

10.51

1.1

—

(3020491) Glucose [Moles/volume] in Blood

216

2.42

10.51

2.2

1.5

7.84

5.69

mmol/l

4.23

167

(3030313) Adrenal Ab [Titer] in Serum

5.62

10.44

1.4

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.65

10.17

1.5

1.4

—

(3002619) Bacteria identified in Specimen by Culture

3.82

9.86

1.3

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

245

1118

1.58

9.86

1.7

1.5

40.51

43.69

nmol/l

1.13

237

1102

(3035933) Granulocytes/100 leukocytes in Blood

134

2.78

9.83

1.4

1.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.22

9.83

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

9.54

9.52

1.1

—

(3042517) Benzodiazepines panel - Urine

10.45

9.47

1.9

4.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

147

592

1.79

9.46

1.4

1.3

29.91

31.17

u/l

0.15

124

493

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

184

2.45

9.37

3.7

2.2

223.86

206.27

u/l

0.58

184

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

872

4999

1.27

9.31

2.1

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

139

2.68

9.21

1.6

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

9.71

9.15

29.4

3.4

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.30

9.13

5.4

8.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

+∞

9.11

1.1

0.0

—

(4034850) Laboratory test

239

1106

1.56

9.09

11.3

5.8

—

(3051339) Copper [Moles/volume] in Blood

20.02

8.95

1.1

1.4

16.67

16.18

umol/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.13

8.89

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

188

827

1.64

8.83

1.8

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

15.32

8.80

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

142

579

1.76

8.80

2.3

2.6

9.83

8.45

umol/l

0.23

110

421

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

11.05

8.74

6.4

5.8

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

8.49

8.56

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

229

2.22

8.52

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

9.20

8.47

1.1

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

157

1816

0.61

8.44

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

966

5671

1.24

8.39

2.2

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.36

8.18

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.89

8.18

1.2

0.31

0.28

g/l

1.26

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.64

8.15

1.8

1.5

8.96

9.63

ug/l

0.25

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

9.35

8.10

1.0

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.37

8.06

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

11.92

8.02

1.1

2.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.81

7.73

1.6

1.8

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

10.72

7.68

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

144

1656

0.61

7.59

1.5

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

6.79

7.54

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

293

2915

0.71

7.49

1.7

1.6

—

(3011288) Drugs identified in Urine by Screen method

237

1150

1.48

7.32

4.1

1.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

+∞

7.29

3.1

0.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.60

7.27

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

969

0.51

7.27

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.99

7.17

2.1

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

8.17

7.16

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

111

1340

0.59

7.15

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

439

2382

1.33

7.12

4.0

4.1

56.64

54.83

u/ml

0.06

419

2330

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

224

2.11

7.07

1.1

9.51

9.07

iu/ml

0.05

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

7.15

7.02

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1133

0.56

7.00

1.9

1.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

14.30

6.97

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

11.62

6.95

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

198

2.17

6.90

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

7.63

6.89

3.3

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

111

1321

0.60

6.78

1.4

—

(3005033) Fetal Nuchal fold Thickness US

111

1311

0.60

6.59

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.40

6.56

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

139

1555

0.63

6.55

1.4

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

4.12

6.51

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

141

1569

0.64

6.49

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

108

1279

0.60

6.49

1.4

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

126

2.44

6.47

1.1

88.92

93.45

0.51

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

140

1559

0.64

6.47

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

141

1567

0.64

6.46

1.4

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.73

6.41

1.3

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

8.34

6.40

2.5

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.00

6.28

1.0

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

3.50

6.11

5.6

9.2

66.71

75.56

0.58

(3040893) Potassium [Moles/volume] in Capillary blood

9.53

5.93

3.4

3.1

4.50

4.49

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

14.29

5.89

1.7

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

5.72

5.77

4.0

8.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

439

2460

1.29

5.70

2.0

1.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

275

1444

1.37

5.60

2.5

1.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.53

5.56

1.1

1.2

117.28

109.06

0.79

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

11.91

5.51

1.1

1.2

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

+∞

5.46

8.3

0.0

76.17

—

e6/l

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

5.46

1.2

0.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1313

8239

1.16

5.46

2.9

2.8

0.80

0.85

ug/l

0.42

886

5081

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

133

2.26

5.40

1.8

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.80

5.37

2.9

1.1

—

(44813793) Dust mix specific IgE antibody measurement

225

1.94

5.33

1.1

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.89

5.22

2.7

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

10.21

5.18

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

723

0.53

5.17

1.1

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

184

2.02

5.11

1.8

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.11

5.03

2.5

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

148

2.13

4.93

1.5

1.3

4.51

4.90

umol/l

0.25

134

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.31

4.92

2.6

1.8

0.42

0.46

u/field

0.08

(3002523) Influenza virus A Ag [Presence] in Specimen

167

825

1.45

4.86

1.3

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

5.27

4.84

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

125

582

1.54

4.83

1.7

1.5

—

(3007919) Fasciola sp Ab [Titer] in Serum

10.72

4.80

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

4.80

1.9

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

4.80

1.9

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

4.80

1.9

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

7.15

4.74

3.5

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

166

825

1.44

4.70

1.3

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

4.66

4.69

3.3

2.0

11.11

30.36

—

(3039443) Prostate specific Ag panel - Serum or Plasma

100

1099

0.65

4.48

1.4

1.6

—

(3009992) Blasts/100 cells in Bone marrow

11.43

4.43

2.4

1.4

2.50

26.20

—

(3046861) Legionella sp Ag [Presence] in Urine

7.15

4.35

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.55

4.33

1.0

1.1

1.81

1.50

umol/24h

0.50

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

6.05

4.29

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

6.05

4.29

4.9

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.38

4.26

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

3.71

4.25

1.1

1.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

193

1005

1.38

4.24

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

410

2371

1.25

4.19

1.5

1.3

26.23

31.99

iu/l

2.58

341

2025

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.50

4.12

1.2

—

(40768800) Prostate Pathology biopsy report

111

1169

0.67

4.07

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

3.35

3.98

3.1

1.4

7.07

6.42

mmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

187

1.88

3.97

1.2

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

530

3169

1.21

3.94

2.0

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

4.77

3.93

1.3

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

4.77

3.93

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.00

3.88

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.91

3.73

14.6

7.8

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.50

3.71

1.0

19.45

22.38

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.50

3.71

1.0

38.39

36.77

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.01

3.63

1.6

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.29

3.61

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

144

1.94

3.52

1.1

1.0

9.29

10.81

u/ml

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

3.06

3.50

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

310

1.62

3.46

1.1

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

4.37

3.41

1.8

1.3

287.55

170.77

ng/l

0.57

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.61

3.39

1.1

1.0

0.06

0.04

u/ml

0.15

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.42

3.39

1.1

1.5

0.28

0.26

nmol/l

0.06

(3017937) Magnesium [Moles/time] in 24 hour Urine

6.35

3.35

1.1

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

6.35

3.35

1.3

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.47

3.20

3.9

2.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

352

0.49

3.20

1.1

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

397

0.52

3.14

1.4

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

107

533

1.44

3.13

1.2

—

(3019174) dRVVT (LA screen)

3.93

3.12

1.3

1.2

—

(3016135) IgD [Mass/volume] in Serum

8.57

3.04

1.3

1.0

21.05

26.62

mg/l

—

(3011048) Pyruvate [Moles/volume] in Blood

8.57

3.04

1.5

1.8

89.83

84.40

umol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

8.57

3.04

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.34

2.91

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.60

2.86

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.30

2.84

1.0

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.56

2.76

1.1

—

(3016879) Cocaine [Presence] in Urine

308

1833

1.21

2.53

2.4

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.08

2.48

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.57

2.43

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.25

2.41

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

242

1.57

2.41

1.3

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.14

2.38

1.0

—

mmol/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.36

2.37

1.2

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.29

2.26

1.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.57

2.21

1.1

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.76

2.19

1.3

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

456

0.64

2.13

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.03

2.04

1.1

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

3.57

1.99

3.0

1.5

245.29

235.57

umol/l

—

(3032641) Amino acids panel - Urine

5.10

1.98

1.4

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

121

1.71

1.92

1.0

7.80

11.89

u/ml

0.58

(3041806) Other cells [#/volume] in Blood by Manual count

209

0.51

1.84

2.1

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.46

1.81

1.2

1.0

—

(3049233) Organic acids panel - Urine

4.46

1.81

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.86

1.78

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.86

1.78

1.4

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.81

1.68

1.0

1.1

0.26

4.66

u/ml

0.82

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

174

1488

0.83

1.60

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

384

1.34

1.57

3.4

6.0

244.59

75.82

u/ml

0.52

139

(3028300) Cannabinoids [Presence] in Urine

325

2037

1.14

1.54

2.4

1.5

—

(3034614) HLA Ag [Interpretation]

3.06

1.54

1.5

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.57

1.54

1.0

1.2

198.20

222.40

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

321

2017

1.14

1.48

2.4

1.5

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.63

1.48

2.7

1.3

13.73

28.49

nmol/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.30

1.47

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.30

1.40

1.9

1.2

435.78

308.54

umol/24h

—

(3027008) Opiates [Presence] in Urine

322

2038

1.13

1.36

2.4

1.5

—

(3022475) Manganese [Moles/volume] in Blood

2.22

1.35

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

419

0.71

1.35

1.1

1.3

1.50

1.56

g/l

0.92

419

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

199

1.44

1.34

2.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.98

1.31

1.0

12.20

7.08

u/l

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

131

1.53

1.27

1.7

2.5

109.20

121.99

ng/l

0.18

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.75

1.22

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

100

582

1.23

1.18

1.2

1.3

7.38

6.45

mmol/l

2.75

504

(3020650) Glucose [Presence] in Urine

111

1.55

1.16

2.3

1.2

—

(40768793) Breast Pathology biopsy report

142

1192

0.85

1.14

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

286

0.70

1.08

2.0

2.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

112

949

0.84

1.03

3.7

3.4

40.75

36.92

u/ml

0.12

106

917

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

109

1.51

1.02

2.2

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

125

758

1.18

1.01

1.6

1.4

0.25

0.43

nmol/l

3.69

105

592

(3017509) Phencyclidine [Presence] in Urine

1.79

0.91

1.4

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.97

0.90

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.83

0.89

1.0

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.68

0.83

17.0

9.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

128

1.40

0.80

1.0

—

(3013762) Body weight Measured

1.86

0.80

1.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

765

5184

1.06

0.78

1.4

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

113

706

1.14

0.69

1.4

3.62

5.38

ug/l

0.61

620

(4281824) Cell count and differential, peritoneal fluid

103

641

1.15

0.67

1.3

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

240

1858

0.92

0.61

1.5

1.4

—

(3027944) Amphetamines [Presence] in Urine

304

2022

1.08

0.59

2.3

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

271

1795

1.08

0.59

2.1

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

349

0.82

0.59

1.1

4.34

6.89

u/ml

0.22

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.52

0.50

11.4

4.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

131

851

1.10

0.48

1.1

0.57

1.43

u/ml

2.03

386

(3010726) Horse dander IgE Ab [Units/volume] in Serum

133

866

1.10

0.47

1.1

0.70

2.38

u/ml

3.47

446

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1119

8223

0.97

0.46

1.5

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

151

990

1.09

0.46

1.1

1.59

2.52

u/ml

0.82

511

(3003888) Timothy IgE Ab [Units/volume] in Serum

136

889

1.09

0.45

1.1

3.57

6.61

u/ml

2.05

479

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

427

0.87

0.43

1.4

1.2

159.46

197.37

pmol/l

1.96

427

(3015183) Erythrocyte sedimentation rate

209

1.20

0.42

1.2

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.42

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.33

0.40

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

271

1.16

0.39

4.7

7.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

159

1.21

0.38

2.7

2.4

162.67

162.56

nmol/l

0.00

140

(3025130) Human papilloma virus identified in Specimen

114

747

1.09

0.38

1.8

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

192

0.82

0.37

6.6

6.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

192

0.82

0.37

3.3

3.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

320

0.87

0.34

1.1

1.0

0.18

1.64

u/ml

0.68

(3008607) Semen analysis panel

1.32

0.31

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.23

0.28

1.1

1.2

0.02

10.65

u/ml

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

104

693

1.07

0.26

1.1

2.32

4.82

u/ml

1.26

296

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

280

2073

0.96

0.23

1.8

1.5

7.66

2.63

mg/l

4.21

228

1317

(3001556) Androgen free Index in Serum or Plasma

1.23

0.22

3.2

1.2

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.22

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

136

1.16

0.21

1.1

0.21

10.58

u/ml

1.10

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

6.2

—

0.26

—

(3000285) Sodium [Moles/volume] in Blood

1.22

0.20

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

108

731

1.06

0.19

1.1

7.47

3.93

u/ml

0.34

363

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

289

0.91

0.18

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

339

1.05

0.10

1.1

2.45

3.46

u/ml

0.20

(42870560) Thyrotropin [Units/volume] in Cord blood

1.15

0.10

1.0

9.56

8.54

mu/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.81

0.08

1.2

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.86

0.08

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

595

0.97

0.07

1.0

1.1

0.41

0.53

u/ml

0.13

153

(40765089) Chromosome analysis panel - Blood by G-banded

189

0.94

0.06

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

218

1.05

0.06

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

128

1.00

0.00

1.9

3.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.85

-0.00

1.0

1.2

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_INFECTIONS – Infections, IBD-co-morbidities

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Infections, IBD-co-morbidities

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Infections, IBD-co-morbidities (IBD_INFECTIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints